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SUMMARY 
Electromagnetic fields are present wherever electricity is created.  The frequency 
range of these electromagnetic fields is from extremely low to extremely high.  
The fields present in domestic areas fall within the extremely low frequency range.  
These fields are created by domestic electrical appliances and 
telecommunication. 
There has been much debate on the effect of exposure to these fields on human 
health.  Research has not yet been able to prove adverse effect of these fields on 
human health.  In fact, the benefits of magneto therapy has been recognized and 
used for several decades. 
Recently a specific electromagnetic signal has been under investigation for its 
ability to stimulate the immune response.  This signal is produced by a patented 
generator, called Immunent Activator.  Studies performed with the Immunent 
Activator signal on farm animals revealed increased feed conversion and 
decreased intestinal lesions of animals with intestinal infections.  Most of the 
research was performed on fish and fowls and evidence of similar findings in 
mammals is lacking. 
In the current study, mice were exposed to the Immunent BV signal for seven 
days, after which immune cell counts were performed and compared to the 
immune cell counts of a control group of mice which received no electromagnetic 
exposure. 
It was found that the T-lymphocyte population of immune cells in the exposed 
group of mice was statistically significantly higher than that of the control group.  
The neutrophil count was statistically significantly lower in the exposed group 
compared to the control group. 
These findings revealed evidence of immune stimulation in the mice which were 
exposed to the Immunent Activator signal.  Suggestions for further research could 
be made with regard to specific mechanisms of immune stimulation.  The findings 
of this and other related studies hold benefits for the farming and health industry. 
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CHAPTER 1 
INTRODUCTION 
1.1 Introduction 
Advanced electrical technology has created an electromagnetic environment in 
which people live, work and play, resulting in constant concern about the 
environment and human health.  Life without electricity in the 21st century is 
unthinkable since almost our entire existence has become dependent on 
electricity and wireless telecommunication (Havas, 2000).  However, where 
electricity is generated, electric fields (EF) and magnetic fields (MF) are created 
(Boorman et al., 1999).  The MFs created in this instance are known as 
electromagnetic fields (EMFs).  EMFs constitute a wide spectrum, ranging from 
extremely low frequencies (ELF) to high frequencies (HF).  Exposure to EMFs in 
the HF ranges is extremely harmful to animals and humans; hence these fields 
are strictly monitored within controlled environmental limits (Blank, 1995; Ahlbom 
& Feychting, 2003). The fields in the intermediate range are under constant 
investigation as they have yielded extremely controversial results.  It is for this 
reason that ELF-EMFs have recently become a new focus of investigation. 
People are exposed to EMFs in the ELF spectrum on a daily basis, since 
household appliances, computers and telecommunication systems fall within this 
range (Boorman et al., 1999; Cifra et al., 2011).  With constant exposure of 
people to the EMFs created in our homes and work environment, it is inevitable 
that questions have been raised as to whether exposure to ELF-EMF has any 
influence on the human body or human health.  Consequently, extensive 
research has been conducted in the field of electromagnetism and the possible 
health effects due to exposure to ELF-EMFs. 
Initially, research concentrated on the adverse effects that ELF-EMFs have on 
the human biological system (Wertheimer & Leeper, 1979; Ahlbom & Feychting, 
2003).  Some scientists have claimed that exposure to ELF-EMFs can hold health 
risks, whereas others have claimed that these EMFs cannot interact with the 
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human body (de Kleijn et al., 2011).  It is well documented that exposure to 
higher field strength EMFs can be detrimental to human health (Wertheimer & 
Leeper, 1979). However, it was also found that short-term exposure to ELF-EMF 
does not have any detrimental effect on human biological systems (Hashish et al., 
2008), but that long-term exposure can cause chronic stress, resulting in tissue 
damage (de Bruyn & de Jager, 1994; Ahlbom & Feychting, 2003; Bonhomme-
Faivre et al., 2003). 
The finding that short-term exposure to ELF-EMF is not detrimental to the human 
body redirected the research interest to EMFs in the ELF range.  These fields are 
produced by power lines and day-to-day domestic electrical devices (Boorman et 
al., 1999; de Kleijn et al., 2011).  The National Institute of Environmental Health 
Sciences (NIEHS) could not report substantial evidence that ELF-EMF adversely 
affects human health (NIEHS, online).  Several studies were conducted to 
determine the effect of ELF-EMF on the immune system, but the findings were 
negative.  An opinion was adopted in Europe by the Scientific Committee on 
Emerging and Newly Identified Health Risks (SCENIHR) that there is no 
conclusive evidence of adverse health effects as a result of exposure to ELF-
EMF; hence further investigations are warranted (SCENIHR, 2009).  Other 
research efforts also indicated that there is no conclusive evidence that exposure 
to low field strength EMFs poses a health risk (Boorman et al., 1999; Repacholi & 
Greenbaum, 1999; Ahlbom & Feychting, 2003; Cifra et al., 2011). 
The possibility of potential therapeutic benefits of exposure to ELF-EMF has 
opened a new area of interest in this field.  Various studies have shown the 
possibility of therapeutic benefits from short-term exposure to ELF-EMFs (Blank 
& Goodman, 2000; Simko & Mattson, 2004; Markov et al., 2006; Goraca et al., 
2010; Waite et al., 2011).  With extensive research performed in the field of 
health effects due to exposure to ELF-EMF, an area of specific interest arose in 
the role of the immune response.  There appears to be a notion that short-term 
exposure to ELF-EMF could beneficially affect the immune system.  It was found 
that short-term exposure to fields in the ELF range affects the blood cell 
concentrations and results in lymphocyte proliferation (de Kleijn et al., 2011).  
This same research group indicated an increased phagocytic activity in 
 3 
 
macrophages, hence implicating an effect on the innate immune response.  
Substantial in vitro studies were performed on chickens and fish (Cuppen et al., 
2007; Elmusharaf et al., 2007).  Cuppen et al. (2006) hypothesized that ELF-EMF 
could boost or stimulate the immune system by “putting it into a state of alert due 
to cytokine production”.  A similar suggestion was proposed by Aldinucci & 
Pessina (1998).  Several authors have suggested that short-term exposure to 
ELF-EMF can stimulate the immune response, specifically on a cellular level, 
leading to the production of cytokines (Blank & Soo, 1992; Simko & Mattson, 
2004; Cuppen et al., 2007; Elmusharaf et al., 2007; de Kleijn et al., 2011; Waite 
et al., 2011).  
If shown to be correct, the hypothesis by Cuppen et al. (2007) could be a 
breakthrough in the medical field.  It could possibly imply toward boosting an 
early immune response (de Kleijn et al., 2011).  Since the hypothesis was based 
on results from studies performed on chickens, fish and in vitro studies, it seems 
necessary to expand the investigations to in vivo studies on mammals and, 
ultimately, on humans.  However, before embarking on such studies there is a 
need for duplication of existing evidence to show that short-term exposure to 
ELF-EMF can promote innate immunity and for finding new evidence to support 
this theory.  With limited evidence of these findings in mammals, supportive 
research can strengthen the suggestions made by Cuppen et al. (2007). 
Recent studies indicated that exposure to a specific EMF signal (the Immunent 
Activator signal with multiple waveforms ranging from 20 - 5000 Hz) decreased 
the mortality in fish (Cuppen et al., 2007) and also improved the feed conversion 
in chickens (Elmusharaf et al., 2007).  In addition, this same signal revealed 
enhancement of the immune system when a study on chickens, infected with 
coccidiosis, indicated reduced intestinal lesions after exposure to this specific 
signal (Elmusharaf et al., 2007). 
The Immunent Activator signal is created by a device designed and built by 
Immunent BV (Werfberg 12, Veldhoven, The Netherlands) which emits a specific 
ELF-EMF signal consisting of multiple, highly complex waveforms and intensity.  
These waveforms and intensity differ from those standard therapeutic signals one 
would expect them to conform to (Waite et al., 2011).  Using this patented signal, 
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several research studies have shown that short-term exposure to the signal 
enhances the immune system (Blank & Soo, 1992; Simko & Mattson, 2004; 
Cuppen et al., 2007; Elmusharaf et al., 2007; de Kleijn et al., 2011). 
Studies assumed an effect at cellular level, where cells respond to EMF by 
reacting as they would to an unspecific stressor (Simko & Mattsson, 2004).  
However, the proposed hypothesis by Cuppen et al. (2007) needed to be further 
investigated, specifically in mammals.  Research will also need to focus on ELF-
EMF signal variables with respect to the specific EMF intensity, waveform and 
frequency.  Further investigation on the biological mechanism of action could also 
contribute toward outcomes in this regard. 
 
1.2 Problem Statement 
If there is evidence that short-term exposure to the ELF-EMF Immunent Activator 
signal can stimulate the immune system of fish and chickens (Cuppen et al., 
2006), the question arises whether it would be possible to reproduce the findings 
in mammals, specifically mice (Mus. musculus) and, by so doing, validate the 
findings of previous research in lower animals. It is therefore important to test the 
effect of the ELF-EMF Immunent Activator signal on the immune system of 
mammals. 
 
1.3 Aim of the study 
The aim of this study was to investigate whether short-term exposure to ELF-
EMF from the specific Immunent Activator signal influenced the immune system 
in mice (Mus. musculus) and to determine if the duration of exposure to the signal 
had any significant effect on the results.  
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1.4 Objectives 
The following were the objectives of the study: 
 Obtain a sample of one hundred experimental mice. 
 Set up a housing facility in which mice can live comfortably while being 
exposed to the Immunent Activator signal. 
 Divide mice into four groups and expose them to the Immunent Activator 
signal as follows: Present in same sequence as in Figure 1.1. 
o Continuous exposure (24 hours) 
o Exposure of four hours per day 
o Exposure of one hour per day 
o Control group which received no (sham) exposure 
 Following exposure for one week, perform the following biological analyses: 
o Full blood count 
o Immunophenotyping, using CD3, CD4, CD8 and CD19 markers (to 
determine total T-lymphocyte, T-helper, T-suppressor and B-
lymphocyte counts) 
 Data analyses: 
o Compare data from exposure groups with the control group 
o Compare data among the three exposure groups.  
Figure 1.1 presents a summary of the objectives and the design of the study. 
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Figure 1.1: Schematic layout of study protocol  
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1.5 Summary 
As several studies have shown that the immune system in fowl and fish can be 
activated by exposure to ELF-EMFs, it left the scope for supportive research to 
be conducted in order to determine whether the same results could be achieved 
in mammals.  This research would therefore extend previous studies to include 
higher animals and it would test additional immune parameters to those tested in 
earlier studies.  In addition to this, the length of exposure would be investigated to 
determine if the desired effects could be influenced by the duration of exposure. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Introduction 
Considering the nature and origin of electromagnetic fields (EMFs), it is inevitable 
that questions will arise as to whether EMFs have any biological effect on the 
human body and, moreover, by which biological mechanisms this effect takes 
place.  Life itself is an “electromagnetic event” (Markov et al., 2006), and it is well 
known that exposure to HF-EMFs (from the ionizing segment of the spectrum) 
can cause serious tissue damage, such as burns (Blank, 1995; Ahlbom & 
Feychting, 2003).  For this reason strong regulations have been established 
internationally to prevent exposure to these fields.  Evidence has been provided 
that exposure to low frequency (LF-EMFs) in individuals living close to power 
stations (Wertheimer & Leeper, 1979) and long-term exposure to lower field 
strengths (de Bruyn & de Jager, 1994) could be detrimental to human health.  
There is, however, no evidence that short-term exposure to extremely low 
frequency EMFs is detrimental to human health (Boorman et al., 1999; Repacholi 
& Greenbaum, 1999; Ahlbom & Feychting, 2003). 
It is mostly household appliances that create ELF-EMFs, and the implications of 
exposure to these EMFs have been questioned, since the exposure of individuals 
to these fields occurs on a daily basis.  Although literature has supplied a plethora 
of controversial evidence as to whether ELF-EMFs are harmful or not, there is 
currently insufficient research evidence to substantiate any of the findings.  
Where strong evidence has been provided that EMFs could cause adverse 
effects in humans (Wertheimer & Leeper, 1979), the mechanism of action is 
unknown (Ahlbom & Feychting, 2003). 
The major component of research performed in this field has been directed 
toward the harmful effects of EMFs on the human biological system.  Although 
magneto therapy with ELF-EMF has been used for almost five decades (Vallbona 
& Richard, 1999), research has begun to consider the possibility of additional 
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therapeutic benefits of some of these fields due to their ability to induce the 
synthesis of stress proteins (Blank & Goodman, 2000).  However, it seems that 
this benefit is only obtained from short-term exposure, as de Bruyn & de Jager 
(1994) have indicated that long-term exposure can be detrimental due to chronic 
stress induction. 
 
  
 10 
 
2.2 Electromagnetism 
If a magnet is allowed to spin around in the vicinity of a coil, electricity will be 
generated (Boorman et al., 1999).  This forms the basic principle according to 
which electricity is generated in power stations.  The area around the magnet 
forms the MF.  MFs are lines of force that cannot be seen.  The power of the 
magnetic field is strongest closest to the magnet.  EFs and EMFs will be created 
wherever electricity is generated, transmitted or used (Boorman et al., 1999). 
EMFs consist of two components; electric and magnetic fields.  EFs are created 
due to the presence of an electric charge.  This is the power (extent) and 
direction of the force it exerts on a positive electric charge.  A magnetic field is 
created by the movement of electric charges.  This movement forms an electric 
current which gives the number of charges per second passing through the 
conductor (a conductor being a substance which allows electricity to flow through 
it).  The majority of electricity used consists of alternating currents.  The current is 
pulsed to-and-fro during a specific length of time.  It is the number of times a 
current is pulsed to-and-fro during a specific time that is known as the frequency, 
which is measured in Hertz (Hz).  The more alternating currents within a given 
time, the higher the frequency will be.  It is then this frequency that creates the 
electric and magnetic field, of which the strength is proportional to the frequency 
(e.g., 50 Hz alternating current will create a 50 Hz electric and magnetic field).  
The magnitude of the magnetic field is proportional to the current flow in a 
conductor, regardless of the voltage present (Boorman et al., 1999). 
EMF signals vary considerably in their physical characteristics.  The signal from 
one field differs from the other even if there is just one different variable (Markov 
& Hazlewood, 2009).  When looking closely at the physics and engineering of 
EMF signals, there is always a basic frequency with a range of additional 
frequencies which creates the harmonics of the signal.  Hence, when dealing with 
a specific signal, it is essential to understand and describe the harmonics of that 
signal. 
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2.2.1 Measurement of electromagnetic field strength 
Electromagnetic fields are indicated as frequency or wavelength, where the 
wavelength is inversely proportional to the frequency (Ahlbom & Feychting, 2003).  
The shorter the wavelength, the higher the frequency will be.  Figure 2.1 
demonstrates the relationship between wavelength and frequency and illustrates 
some sources of these fields.  The lower electromagnetic fields refer to the 
frequency and the higher electromagnetic fields refer to wavelength.  Voltage 
determines the extent of the electric fields in a location, the strength of which is 
measured in volt/meter (V/m) or kilovolt/meter (KV/m) (Boorman et al., 1999). 
Current refers to the amount of the MFs in a location (strength = magnetic flux 
density or magnetic strength, where magnetic flux density and magnetic strength 
are proportional to the amount of current).  Magnetic flux density is measured in 
gauss (G), or tesla (T), where 1mG is equivalent to 0,1µT.  Magnetic strength is 
measured in standard international (SI) units of amperes/meter (A/m). 
2.2.2 The electromagnetic spectrum 
The electromagnetic spectrum ranges from ELF to HF wavelengths.  Included in 
this spectrum are various sources and strengths of EMFs, such as x-ray radiation, 
ultraviolet (UV) radiation, radio frequency (RF) fields, static fields and visible light 
(Ahlbom & Feychting, 2003).  The characteristics of EMFs depend on their 
frequency or wavelength (Ahlbom & Feychting, 2003), which will determine the 
energy they create.  The ionizing segment of the electromagnetic spectrum is 
associated with heat production and can break chemical bonds (Ahlbom & 
Feychting, 2003).  Exposure to these fields of radiation will cause cell damage  
(Blank, 1995).  These fields include the HF fields with a short wavelength 
(Ahlbom & Feychting, 2003).  They begin with the UV-band and extend to gamma 
rays.  The non-ionizing segment, on the other hand, is not associated with heat 
production and cannot break chemical bonds.  This segment includes LF fields 
with a longer wavelength.  The fields associated with the use of mobile 
telecommunication which fall within the RF band include frequencies between 
450 - 2500M Hz.  However, it is obvious that microwaves that fall within 109 - 1011 
Hz) that are used for cooking will cause cell damage (Blank, 1995) as they are 
somewhat higher than RF.  At the lowest end of the LF band are ELF fields which 
are associated with general production of electricity, including frequencies of 
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approximately 50 - 60 Hz (Ahlbom & Feychting, 2003).  In most countries, 
electrical power is used at 50 - 60 Hz (Hashish et al., 2008).  LF fields are found 
between the latter two fields and have frequencies of up to 300G Hz.  The 
distinction between the ionizing and non-ionizing spectrum is at approximately the 
upper end of the UV band. 
 
Figure 2.1: The electromagnetic spectrum, its frequencies, wavelengths and the sizes of 
the wavelengths (University of Virginia online (image from Andor Technology online)) 
2.2.3 Sources of electromagnetic fields 
The electromagnetic spectrum covers many different types of electromagnetic 
fields, such as x-ray radiation, UV radiation, radio frequency fields, static fields 
and visible light (Ahlbom & Feychting, 2003).  Electric fields can occur naturally in 
the atmosphere (approximately 120 - 150 V/m), but in thunderstorms 
theImmunent Activatory can reach up to 20 KV/m (Repacholi & Greenebaum, 
1999).  Naturally occurring environmental levels are also found, but it is not 
certain at which field parameters these can be determined (Repacholi & 
Greenebaum, 1999).  High electrostatic fields (20 KV/m) can also be found near 
equipment using high voltages, including household appliances such as television 
 13 
 
sets.  Most public exposure to electromagnetic fields comes from electrical 
appliances, household wiring and alternating current (AC) transmission and 
distribution lines. 
Examples of exposure levels include the following ELF-EMF strengths (Repacholi 
& Greenebaum, 1999): 
 static geomagnetic field and naturally occurring  - 0.01 - 0.1 mT (millitesla) 
 direct current (DC) lines - 22 μT 
 workers using DC equipment – 50mT 
 occupational exposure at magnetic resonance imaging (MRI) departments 
(MRI operators – 5 mT and patients undergoing MRI – 2.5T) 
 household appliances – 10-15 μT 
A study was performed by Farag et al. (1998) to determine the most common 
exposure that people experience in a domestic environment.  They tested 
residential sources such as electrical appliances in the home, grounding systems 
of residence lights and overhead power distribution lines.  The largest EMFs were 
created by appliances in the homes, and the largest fields were experienced 
closest to the appliances while in use.  The fields decreased exponentially as the 
distance from the appliance increased.  The authors described two types of 
residential EMF sources.  One is known as “area sources”.  In these cases the 
fields extend for some distance beyond the source (e.g., currents on pipes, power 
and distribution lines).  The other is known as “local sources”.  In the latter case 
the fields are confined to the vicinity of the source (e.g., televisions, toasters, 
washing machines, hair dryers, to name a few). 
2.2.4 Dosimetry 
Dosimetry is also known as the “dose”.  This is the amount of exposure which can 
cause a biological effect as a result of the exposure (Repacholi & Greenebaum, 
1999).  Dosimetry is measured at or near the point of interaction of the field with 
the biological system.  Macrodosimetry involves exposure of the entire body, 
tissues or an organ, whereas microdosimetry involves exposure at cellular or sub-
cellular level.  In the clinical and scientific communities, the concept of dosimetry 
can often be misinterpreted.  According to Markov & Hazlewood (2009), 
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dosimetry can be viewed from a physical and a biophysical point of view.  
Physical dosimetry relates to the characteristics of the signal from an engineering 
point of view.  Biophysical dosimetry is the amount of EMF received by target 
tissues.  The latter is, in fact, the “dose”.  In addition to the fact that EMFs vary 
considerably in their physical characteristics, there are also other variables (e.g., 
distance) that will determine the actual “dose” of exposure.  The time or duration 
of exposure and the strength of the fields will determine the dosimetry.  Some 
authors refer to the duration of exposure as the “working time” (Goraca et al., 
2010). 
2.2.5 Biological effects of extremely low frequency electromagnetic fields 
Since there is no conclusive scientific evidence that LF-EMFs and ELF-EMFs can 
cause health effects, investigations in this field are on-going.  The strongest 
evidence found was that of a substantially increased risk of childhood cancer in 
subjects living in close proximity to power lines (Wertheimer & Leeper, 1979).  
Considering the lack of substantial evidence, research has hypothesized the 
possibility of adverse health effects due to long-term exposure to these field 
strengths of EMFs and it was found that there was evidence of a possible cause, 
but it was concluded that the mechanism was unknown (Ahlbom & Feychting, 
2003).  De Bruyn and de Jager (1994), however, suggested that long-term 
exposure to ELF-EMF resulted in adverse health effects due to the induction of 
chronic stress, hence implicating the chronic stress factor as a possible 
mechanism for adverse health effects.  These findings confirmed similar findings 
by Mevissen et al. (1998).  Feychting and Ahlbom (1993) demonstrated that the 
effect of exposure to LF-EMF depended on the dose of exposure.  They 
postulated that the amount of EMF that an individual was exposed to (dosimetry) 
contributed to the increased risk of adverse health effects. 
The duration of exposure plays a very important role in the outcome of effects 
that ELF-EMF has on biological systems.  Goraca et al. (2010) confirmed that the 
duration of exposure or working time had an effect on the results.  With exposure 
of rats to a 40Hz (7 mT) field for thirty minutes per day for two weeks, there was 
no alteration in reactive oxygen species (ROS) generation of heart tissue, but 
when exposing them to the same signal for sixty minutes per day for two weeks, 
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there was an increased ROS production and decreased antioxidant production.  
Therefore, they concluded that the effect was dependent on working time (i.e., 
duration of exposure). 
Havas (2004) is convinced that scientists are very close to unravelling the effects 
of ELF-EMF on biological systems and the biological mechanisms involved in this 
process, arguing that the outcomes will be beneficial.  This strongly warrants the 
necessity for research to achieve a specific outcome. 
2.2.5.1 Public concern 
The consequences of exposure to LF-EMFs and ELF-EMFs are of great public 
concern, since these are the fields the public are exposed to on a daily basis.  
Havas (2000) refers to these fields as “techno fields” since they are the fields 
created by technology.  For this reason investigations have been ordered by 
various governments to determine the possible health effects due to exposure to 
these EMFs (Havas, 2000).  In 1992 the United States (US) congress advised the 
National Institute of Environmental Health Sciences (NIEHS), the National 
Institute of Health (NIH) and the US Department of Energy (DOE) to initiate 
research and to collect evidence on the potential health risks from being exposed 
to ELF-EMF (Boorman et al., 1999).  This was an in-depth study to clarify 
whether there are any health risks being exposed to these fields.  The report 
concluded that there was very little evidence showing that exposure to these 
fields posed a health risk, but it could also not be considered safe either.  The 
reason for this conclusion was that there was a lack of consistency in the findings 
in animals and mechanistic studies. 
Despite the research done in this area over the past decade, it is still unclear as 
to whether exposure to ELF-EMF is harmful to human biological systems or not.  
This area of research therefore still needs a great deal of epidemiological studies 
(Hashish et al., 2008). 
2.2.5.2 Therapeutic benefits and applications 
In spite of the proliferation of evidence pointing to the detrimental health effects of 
long-term exposure to LF-EMFs, there is also evidence of beneficial effects from 
short-term exposure to ELF-EMFs (Blank & Goodman, 2000; Simko & Mattson, 
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2004; Markov et al., 2006; Goraca et al., 2010; Waite et al., 2011).  This evidence 
excludes the fact that EMFs have been used therapeutically for centuries.  The 
use of pulsating electromagnetic therapy has been used for more than 50 years 
(Vallbona & Richard, 1999) and the interest in this form of therapy has increased 
immensely in the last few decades (Markov et al., 2006).  The reason for this is 
that “electroceutics” (a term introduced by Markov et al. in 2006) is cheaper and 
less invasive than drugs or surgery.  Moreover, it has fewer side effects than 
those associated with drug treatment (i.e., the administration of pharmaceutics).  
The application of this technology is commonly used in many conditions varying 
from bone fracture and wound healing to treatment of sleep disorders.  In fact, 
EMF devices have been used therapeutically since just after World War II, but 
very little is known about the applications at that time (Markov & Hazlewood, 
2009).  It is specifically the time varying (pulsed) EMFs that are applied 
therapeutically.  The general aim of therapeutic signals is to create a signal that 
mimics the body‟s natural EMFs or, alternatively, alter certain biochemical 
processes in the body (Waite et al., 2011). 
The physics and engineering of EMF signals for therapeutic application are 
designed in a specific fashion to target a specific tissue, or part of a tissue, 
ensuring that the flux density is received by the target.  A specific signal might be 
beneficial for application in one biological area, but not in another (Markov & 
Hazlewood, 2009). 
The indication of a stress response which has repeatedly been implicated (Blank 
& Goodman, 2000; Simko & Mattsson, 2004; Cuppen et al., 2007; Hashish et al., 
2008; de Kleijn et al., 2011) has shown the possibility of therapeutic benefits and 
has opened a new area of interest in these fields.  Studies have shown the 
possibility of therapeutic benefits from short-term exposure to ELF-EMFs (Goraca 
et al., 2010; Marcov et al., 2006; Simko & Mattson, 2004; Waite et al., 2011; 
Blank & Goodman, 2000).  A field commonly applied in magneto therapy is a 40 
Hz, 7 mT exposure for thirty minutes per day, for two weeks (Goraca et al., 2010).  
The question then, once again, arises as to what the mechanism of action is.  
The same stress induction mentioned by de Bruyn & de Jager (1994) is proposed 
to be the possible mechanism of action by Blank and Goodman (2000).  However, 
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Blank and Soo (1996) suggest that overexposure to these EMFs could 
compromise the beneficial effect, which supports the findings of de Bruyn & de 
Jager (1994). 
In a mini review article by Goodman and Blank (1998), the therapeutic application 
of EMFs is reiterated.  Reference was made to Basset (1995), who stated that the 
application of magnetic fields for assistance in healing of bone fractures was 
approved by the Food and Drug Administration (FDA) in 1972.  However, the 
biggest question or void in this area is the availability of research findings 
supporting the biological mechanisms. 
Varani et al. (2002) indicate that exposure to LF-EMF results in an increase of 
A2A adenosine receptor density.  Adenosine interacts with receptors on the 
neutrophil surface as an anti-inflammatory agent.  With this finding in mind, it has 
been proposed that these fields can well be used therapeutically for wound 
healing due to their anti-inflammatory effects. 
Goats (1989) also discuss the various therapeutic applications of pulsed 
electromagnetic energy.  The application can be used for pain, soft tissue injury, 
wound healing and nerve repair. 
2.2.5.3 Biological mechanisms 
Cuppen et al. (2007) propose that the mechanism of action is on a cellular level.  
This group of researchers proposes that EMFs act as the foreign stimulus.  An 
immune response is launched against foreign substances or cells by means of 
promoters such as heat shock proteins and cytokines.  When cells are stressed 
for any reason, there is immediate release of danger signals which then, in turn, 
alert the immune system to launch an action. 
Blank (1995) devoted a great deal of time to investigate the possible molecular 
mechanisms of action that EMFs have on the human biological system.  Blank 
and Soo had also studied the mechanism of action of EMFs on the cell 
membrane enzymes, cytochrome oxidase and Na, K-ATPase (Blank and Soo, 
1992; Blank and Soo, 1996).  They found that EMFs interact with charge 
movements during enzyme function and cause accelerated charge movements in 
 18 
 
enzymes as well as within the deoxyribonucleic acid (DNA) of the cell, thus 
opening up the possibility that EMFs directly interact with cellular DNA. 
Blank and Goodman (2009) state that there is a general acceptance that LF-
EMFs activate DNA to synthesize proteins, this being the mechanism of 
increasing production of stress proteins by cells.  This stress response is a 
natural mechanism of the body to protect itself against potentially harmful 
external influences.  They also point out that the effect that these EMF fields have 
on the body is not only at cellular level, but that they also have physiological 
effects such as changes in heart and breathing rate or muscle activity.  The 
cellular effects and stress proteins will be discussed in more detail later in this 
chapter (i.e., sections 2.5.3 and 2.5.4). 
There is evidence that all cells (not only electrically excitable and nerve cells) 
produce EMFs in the visible light spectrum (Cifra et al., 2011).  This spontaneous 
emission of light by living cells, initially referred to as “mitogenic radiation”, was 
well established in the mid-1900s.  Later it became known as ultra-weak photon 
emission (UPE) or, alternatively, biological luminescence or bio photons.  Based 
on this phenomenon, it was proposed by Cifra et al. (2011) that inter-cellular 
interactions can take place through EMFs and, hence, that EMFs form an integral 
part of biological activity in the body.  Cifra et al. (2011) propose that when cells 
are stimulated and undergo mitosis, there is a fluctuation of electrical charges in 
the cell accompanied by a fluctuation in EMF generation.  The mitochondria are 
thought to be a source of EMF generation since they are an essential source of 
cellular ROS production, although any other cell structure is also considered a 
possible source of EMF generation.  In this same article Cifra et al. (2011) 
discuss the findings of other authors that DNA is one of the main sources of UPE.  
The general consensus is that the main source of UPE is through ROS, which are 
excited molecules (Cifra et al., 2011).  Apart from their review on the theories of 
EMF sources in living cells, Cifra et al. (2011) also investigated the effect of EMF 
on biological systems.  They state that LF-EMFs do have an effect on biological 
systems, since they can penetrate deeper into the tissue.  They can act on a level 
which affects cell interaction; i.e., through DNA, ribonucleic acid (RNA) and 
protein synthesis; hormone production and antioxidant enzyme activity. 
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A significant finding is that of increased free radical production in reaction to 
exposure to EMFs (Simko et al., 2001; Hashish et al., 2007; Goraca et al., 2010; 
Cifra et al., 2011; Mattson & Simko, 2012).  Free radicals are a very important 
mediator in cell metabolism. 
Cifra et al. (2011) also found that it is hard to explain a mechanism of action other 
than thermal effects.  One of the possibilities mentioned is that EMFs interact with 
cellular magnetic nanoparticles.  This indeed shows a possible mechanism at a 
molecular and biophysical level, which will explain the cellular response to EMFs.  
When considering which units of the cell would most probably interact with the 
EMFs, the most probable would be the cellular sodium (Na) ion pump, 
membrane-bound enzymes, membrane macromolecules or cellular calcium (Ca2). 
To summarize the findings by Cifra et al. (2011) on the possible mechanism of 
action, it is clear that cells generate and interact with EMFs.  EMFs interact with 
biological systems at the level of nanoparticles.  This leads to response by cell 
DNA, RNA and macromolecules.  Other than thermal reactions, processes that 
are affected in the cells are, among others, protein synthesis, mitochondrial 
activity, RNA and DNA synthesis, ROS production, free radical production, and 
hormone production. 
It is evident that the biological mechanism of action of EMFs can be explained at 
various levels.  For the purpose of this study, it would be best to look at this effect 
on cellular level, specifically with respect to immune cells. 
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2.3 Immunent 
As mentioned before, signals differ from each other in as much as just one 
parameter may differ from another.  Immunent BV, a company in the Netherlands, 
patented the Immunent Activator which is used to generate extremely low 
frequency electromagnetic fields (retrieved from www.immunent.com).  The 
activator generates electromagnetic fields of extremely low frequency – i.e., 
below all safety guidelines developed by the International Commission on Non-
Ionizing Radiation Protection (ICNIRP) between 5 - 50 µT.  The Immunent (IM) 
Activator signal is indeed different from all other commercial therapeutic signals in 
that the signal consists of multiple waveforms, creating complex, continuously 
changing EMFs with steep rise times and exponential decays, giving it a unique 
oscillation pattern. The unique characteristics of the Immunent signal are that it 
does not have a repeated waveform or pattern and it actually appears to have a 
characteristic of random electronic noise (Waite et al., 2011).  It is this “noise” 
feature that Waite et al. (2011) consider as a likely mechanism of action.  They 
also speculate that the beat periodicity (rhythmic variations) can be a possible 
mechanism of action. 
Extensive experiments were conducted by Immunent (Cuppen et al., 2006; 
Cuppen et al., 2007; Cuppen et al., 2008), in which lower animals (fish and 
chickens) were exposed to extremely low frequency electromagnetic fields.  In 
their first series of in vitro experiments, they found up to 40% increased oxidative 
burst activity in carp phagocytes after exposure to electromagnetic field strengths 
of 1.15 - 50 μT.  Their second series of in vivo experiments involved exposure of 
commercial goldfish to electromagnetic fields similar to those of the first 
experiment.  They found a decreased mortality rate of up to 50% after 18 days of 
treatment.  Their third series of experiments were also in vivo experiments done 
on chicken broilers exposed to coccidiosis.  Up to 40% of the animals showed 
reduced intestinal lesions after exposure to 6.5 μT field strengths. 
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2.4 The Immune System 
Our environment hosts a large number of infectious agents which use the human 
body as a host to thrive and multiply (Delves et al., 2011:3), resulting in disease.  
Fortunately, the body possesses an immune system specifically devised to 
eliminate any external factors which may interfere with the body‟s normal 
biological functions.  The immune system has the ability to discriminate between 
“self” and “non-self”, and in this way eliminates any “non-self” organism or entity 
from the body in an attempt to protect the body (Weir & Steward, 1993:3).  The 
immune system is a complicated, multifaceted system which involves the 
interaction of cells, soluble biologically active substances and complement.  The 
immune system also operates on different levels, depending on the biochemical 
properties of the foreign intruder.  Sometimes the reaction is fast, simple and non-
specific, but there are times when it may be necessary to react in a specific, 
systematic fashion. 
2.4.1 Innate and acquired immunity 
The immune system operates by means of two integral systems; first, the innate 
immune response and later a more specific response called acquired immune 
response.  These two systems are interdependent of each other (Coico & 
Sunshine, 2009:2). 
2.4.1.1 Innate immunity 
Innate immunity is the immunity we are born with and is readily available at any 
given time to destroy any invading pathogen.  It reacts in a non-specific fashion 
and constitutes of factors such as the skin, pH, enzymes, complement and 
specific cells.  This form of immunity is innate in the sense that it is not affected 
by previous contact with any specific organism (Coico & Sunshine, 2009:2).  
Many pathogens can successfully evade our innate immune system in which 
case a more complicated system must be initiated, namely acquired immunity. 
2.4.1.2 Acquired immunity 
Acquired immunity is a process whereby immune cells are stimulated to secrete 
antibodies and biologically active substances, such as cytokines, to kill specific 
pathogens or antigens.  Acquired immunity involves a cellular component and a 
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humoral component (Coico & Sunshine, 2009:18).  Cellular immunity is the 
interaction between immune cells and the direct killing of invading pathogens 
through action of enzymes or cytokines.  Acquired immunity involves mainly three 
types of cells which interact amongst each other.  These cell types are T-
lymphocytes (T-cells), B-lymphocytes (B-cells) and antigen-presenting cells 
(APCs).  APCs are cells that have the ability to engulf foreign particles, process 
them and then present them to the other immune cells (e.g., macrophages).  
Humoral immunity is the activation of specific B-cells to produce specific 
antibodies which will neutralize the foreign antigen (Coico & Sunshine, 2009:2-3). 
Innate and acquired immunity interrelate with one another through the cells and 
biologically active substances in a specialized manner to eliminate foreign 
organisms which gain access to the body.  In Figure 2.2, the intricate 
interrelationship between these two segments of the immune system is illustrated. 
  
 23 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: The interrelationship between the innate and acquired immune system 
(Original figure retrieved from Immune Therapy Research Laboratory) 
 
2.4.2 Cells of the immune response 
Cells, specifically leukocytes, play a major role in the immune response.  
Leukocytes are also known as white blood cells (WBC).  The cells involved in the 
immune response are haematopoietic cells and develop and differentiate from a 
pluripotent stem cell (Coico & Sunshine, 2009:11-25).  These cells have specific 
antigens on their surfaces by which they are phenotyped.  This is known as a 
cluster of differentiation (CD).  Cluster of differentiation is a phenotypic 
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nomenclature used in leukocytes by identifying the specific antigens on the cell 
surface which determine the characteristic nature of that specific leukocyte.  At 
the pluripotent stem cell stage, the cells express CD34 on their surface and are 
therefore indicated as CD34+.  If a cell expresses a specific gene of interest, it is 
referred to as “+” and if it does not express the gene, it is referred to as “-“ (Coico, 
Sunshine & Benjamini, 2003:103).  As they mature into specific cell types 
(unipotent) under the influence of soluble biologically active substances, they lose 
the expression of CD34 on their surface (Coico, Sunshine & Benjamini, 2003:18-
19).  Blood cells follow two pathways of differentiation from these pluripotent stem 
cells.  One develops into red blood cells (erythrocytes), platelets (thrombocytes) 
and granulocytic leukocytes (e.g., neutrophils and monocytes), also known as 
granulocytes.  The other pathway gives rise to development of lymphocytes. 
2.4.2.1 Lymphocytes 
Lymphocytes are central to the specific (acquired) immune response and consist 
of T-cells (CD3) and B-cells (CD19) (Coico, Sunshine & Benjamini, 2003:18).  B-
cells mature and differentiate in the bone marrow and are responsible for the 
production of antibodies which neutralize or kill antigens outside the cells of the 
host.  Often the antigens can penetrate the host cells and it is in this case that T-
cells are needed for the immune response, since they have specific antigen 
receptors on their surfaces.  T-cells mature and differentiate in the thymus and 
are responsible for the launching (activation) and regulation of the immune 
response.  All T-cells express CD3 (i.e., CD3+) on their surface (Coico, Sunshine 
& Benjamini, 2003:103).  T-cells are subdivided, once again, into two subsets.  
The one subset is known as helper T-cells (TH cells) which are CD4+ and the 
other subset is known as cytotoxic T-cells (TC cells) which are CD8+.  Both these 
subsets of T-cells play a role in the antigen-specific immune response, depending 
on the nature or class of the antigen.  These cells need to be stimulated to 
respond through soluble biologically active substances.  Specialized T-cells, 
known as cytotoxic T-cells and natural killer (NK) cells, kill virus-infected cells and 
abnormal cells (Mayer & Nyland, 2010).  NK cells can kill virus infected or 
abnormal cells without any stimulation, which is why they are involved in the early 
stages of these infections (Coico, Sunshine & Benjamini, 2003:15).  CD4+ T-cells 
are referred to as helper-T-cells because they work in cooperation with B-
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lymphocytes, resulting in the production of antibodies by B-cells (Coico, Sunshine 
& Benjamini, 2003:137).  They also cooperate with other T-cells (TC cells) in the 
immune response.  Other functions of TH cells are inflammatory effects, 
regulatory effects and cytokine effects.  TH (CD4+) cells also consist of subsets 
and are defined by the cytokines that they produce.  They can be divided into 
three subsets: TH0, TH1 and TH2.  In response to certain cytokines, TH0 will 
differentiate into TH1 and TH2 (Coico, Sunshine & Benjamini, 2003:137).  Each of 
these subsets synthesizes different cytokines. 
2.4.2.2 Monocytes 
Monocytes migrate from the bone marrow to body tissues and lymphoid organs 
where they are then known as macrophages.  Macrophages play a very important 
role in presenting foreign material to the T-cells, as well as in phagocytosing 
(ingesting) and killing foreign material through the release of oxidative enzymes in 
their cytoplasmic granules  (Mayer & Nyland, 2010). 
2.4.2.3 Neutrophils 
Neutrophils are primarily involved in the nonspecific defences of innate immunity.  
They can phagocytose and subsequently kill infectious organisms with enzymes 
released from their granules.  This is known as oxidative burst activity (Coico, 
Sunshine & Benjamini, 2003:14). 
2.4.2.4 Eosinophils 
Eosinophils are part of the group of granulocytes (they contain granules in their 
cytoplasm) in the leukocyte family (Coico, Sunshine & Benjamini, 2003:14).They 
play an important role in the protection against parasitic infections and are also 
involved in combating allergic conditions (Mayer & Nyland, 2010). 
2.4.2.5 Basophils 
Similar to the function of eosinophils, basophils and mast cells (which resemble 
basophils) release substances from their granules that promote inflammation and 
allergic reactions (Mayer and Nyland, 2010).  They constitute a very small portion 
of the granulocytic leukocyte population.  The granulocytic leukocyte population is 
collectively known as granulocytes.  These include eosinophils, basophils and 
neutrophils. 
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2.4.3 Biologically active substances 
These are substances that are harmful to microorganisms.  Examples of these 
are degradative enzymes, toxic free radicals, inhibitors of growth, acute-phase 
proteins, complement, and cytokines (Coico, Sunshine & Benjamini, 2003:17).  
Most of these substances also play a crucial role in the inflammatory process, 
which comprises an essential component of the immune response. 
2.4.3.1 Cytokines 
Cytokines are substances secreted by immune cells. They play a major role in 
inducing an innate and adaptive immune response and, ultimately, the effector 
phases of the immune response (Weir & Stewart, 1993:12).  Cytokines are 
released by cells in response to a stimulus such as an infective agent, and then 
they control the migration of various cells to areas of infection in the body (Coico, 
Sunshine & Benjamini, 2003:149).  The release of specific cytokines results in the 
activation of other cells.  Cytokines are synthesized by cells and then secreted, or 
they are expressed as proteins on the cell surface.  CD4+ T-cells are a major 
source of cytokine production.  Cytokines can work in a cascade fashion, where 
the one cytokine stimulates the release of the next, or they can have inhibitory 
effects on one another.  The basic functional categories of cytokines include 
immunoregulation, facilitation of immune response (including activation of the 
inflammatory response), and they affect the leukocyte movement and stimulation 
of haematopoiesis (Coico, Sunshine & Benjamini, 2003:152-156).  Table 2.1, 
below, summarizes the most common cytokines involved in the immune response 
and some of their functions (Coico, Sunshine & Benjamini, 2003:153). 
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Table 2.1: Major Cytokines, their source and their major functions in 
the immune system 
Cytokine Source of production Major functions 
IL-1 Monocytes; some other cells Involved in the facilitation of innate iummune 
response and activation of inflammatory 
response  
Fever production, stimulates synthesis of acute-
phase proteins; promotes proliferation of some 
TH cells 
IL-2 TH 0 and TH1 cells T-cell growth factor 
IL-3 TH cells; NK cells; mast-cells Growth factor for Haematopoietic cells 
IL-4 TH2 CD4
+ T-cells; mast-cells Growth factor for B-cells and TH2 CD4
+ cells; 
inhibits TH1 CD4
+ cells 
IL-5 TH2 cells; mast-cells Growth factor for B-cells and eosinophils 
IL-6 T-cells; other cells Involved in the facilitation of innate iummune 
response and activation of inflammatory 
response 
Synthesis of acute-phase proteins; activation of 
T-cells and IL-2 production; stimulates antibody 
production by B-cells 
IL-7 Bone marrow; thymic stromal 
cells; some T-cells 
Growth factor for pre-T and pre-T-cells 
IL-9 T-cells Mast-cell activation 
IL-10 TH2 cells; macrophages Inhibits production of TH1 cells and macrophage 
function 
IL-11 Fibroblasts Stimulates platelet precursor growth 
IL-12 B-cells; macrophages Activates NK cells and promotes the generation 
of TH1 CD4
+ cells 
IL-13 T-cells Growth factor for B-cells; antibody production 
IL-14 T-cells Development of memory B-cells 
IL-15 T-cells; epithelial cells T-cell growth factor 
IL-16 T-cells; eosinpohils; mast cells Chemotactic factor for T-cells; proinflammatory 
IL-17 T-cells Induction of proinflammatory cytokine secretion 
and hematopoietic progenitor cell differentiation 
IL-18 Macrophages; monocytes and 
other cells 
Induces IFNγ production; enhances NK cell lytic 
activity 
IFNα  Involved in the facilitation of innate iummune 
response and activation of inflammatory 
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response 
IFNγ TH1 cells Activates NK cells and macrophages; inhibits 
TH2 CD4
+ cells 
TGFβ Lymphocytes; macrophages; 
platelets; mast-cells 
Inhibits activation of monocyte and T-cell 
subsets; active fibroblast growth and wound 
healing 
TNFα Macrophages; mast-cells Involved in the facilitation of innate iummune 
response and activation of inflammatory 
response 
Inflammatory response involvement; activates 
cells of the immune system and some epithelial 
cells; induces fever and septic shock 
TNFβ T-cells Inflammatory response involvement; involves 
CD8+ cell activity 
GM-CSF T-cells; monocytes Promotes growth of granulocytes and 
macrophages 
M-CSF T-cells; monocytes Promotes macrophage growth 
G-CSF T-cells; monocytes Promotes macrophage growth 
G-CSF = granulocyte colony-stimulating factor; BM-CSF = granulocyte-macrophage colony-stimulating 
factor; IFN = interferon; IL = interleukin; M-CSF = macrophage colony-stimulating factor; NK = natural killer; 
TGF = transforming growth factor; TH = helper T-cell; TNF = tumor necrosis factor 
(Source: Coico, Sunshine & Benjamini, 2003:152-156) 
 
Cytokines can be pro-inflammatory (IL-1β, IL-6, IL-16 or TNFα), anti-inflammatory 
(IL-10) or chemotactic (IL-8) (de Kleijn et al., 2011).  Chemotactic means their 
secretion attracts other cells of the immune response.  Hence, cytokines can 
have activation as well as a regulatory effect on the immune response. 
2.4.3.2 Complement 
Complement is a group of approximately 30 serum and membrane-bound 
proteins which can lyse antibody-coated red blood cells and destroy invading 
pathogens.  It forms part of the innate and acquired immune response.  
Components of the complement system are activated in a cascade of events to 
perform their function (Coico, Sunshine & Benjamini, 2003:205).  This activation 
takes place in response to antigen stimulation. 
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2.4.3.3 Toxic free radicals and ROS 
During the energy metabolism and production in cell mitochondria, metabolic by-
products of O2 are formed which are highly reactive (Thannickal & Fanburg, 
2000).  These free radicals are toxic and can cause severe damage to cell 
structures. They have been implicated in a myriad of diseases of the human body.  
As a protective mechanism, cells produce antioxidant enzymes to neutralize or 
counteract these ROS.  Once the rate of ROS production exceeds the antioxidant 
production, oxidants will accumulate resulting in a condition of “oxidative stress”.  
Although ROS are potentially pathologic, they also have many physiological 
functions.  One of the most important physiological benefits of these oxidative 
species is the killing of pathogenic organisms by phagocytic cells through 
superoxide and hydrogen peroxide production (Sorg, 2004).  Ideally, the 
concentration of ROSs and free radicals should be kept to the minimum for good 
health, but environmental factors are always a problem which contributes to 
oxidative stress. 
2.4.3.4 Acute-phase proteins 
These are a group of powerfully active substances which are released by 
hepatocytes in response to injury and inflammation of body tissues.  This acute 
phase response is initiated by the effect of released cytokines such as IL-1, IL-6 
and INFα.  After their release, these proteins then stimulate other areas of the 
innate immune response (Coico & Sunshine, 2009:16, 168).  As an example, C-
reactive protein (CRP) is one of the acute-phase proteins that are involved in the 
activation of the complement system. 
 
In summary, the immune system is mediated and controlled by cells, cytokines 
and complement.  All of these elements and cells form a fine balance to protect 
the body against harm and disease.  They all work in a symphonic fashion with 
one another to maintain an “immunologic equilibrium” in the body.  Various 
factors influence the immune system, hence causing an imbalance to this critical 
“Yin Yang” of the body (Lafaille & Mathis, 2002).  Some factors include 
temperature changes, hormonal influences, stress, genetics, age and diet (Weir & 
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Stewart, 1993:17-19).  Moreover, there is also evidence that ELF-EMF can 
influence the immune system (de Seze et al., 1993; Cuppen et al., 2006).  
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2.5 Effects of extremely low frequency electromagnetic 
fields on the immune system 
An area of specific concern with respect to the biological effect of exposure to 
ELF-EMF is the immune system.  This is most likely due to strong evidence that 
biological effects of ELF-EMF are demonstrated at cellular level. This is important 
as a large component of the immune system works at cellular level.  Several 
authors have speculated or hypothesized that short-term exposure to ELF-EMF 
can stimulate the immune response, specifically at cellular level, leading to the 
production of cytokines (Blank et al., 1992; Simko & Mattson, 2004; Cuppen et.al., 
2007; Elmusharaf et al., 2007; de Kleijn et al., 2011).  Markov et al. (2006) 
indicate an interaction between ELF-EMF and the immune system, although the 
signal used for their study was a signal with specific characteristics.  This same 
signal that was discussed in section 2.3 was utilized in this study and will be 
discussed in more detail later in the literature review (see section 2.5.5). 
The question arises as to which area of the immune system will be affected by 
these ELF-EMFs.  Going back to the discussion on the possible mechanism of 
action of EMFs, it is obvious that the effect already begins at molecular level.  It is 
logical that for the immune system it will occur at cellular level and exert its 
effects through cell interaction.  ELF-EMF can penetrate tissue and hence cells 
due to their long wavelength (Goodman & Blank, 1998).  It appears that the 
interaction begins at the cell membrane, which then activates signal transduction 
pathways. 
The development of scientific evidence of a mechanism of interaction of EMF on 
the immune system is intense and slow, yet steady (Markov et al., 2006).  Some 
common features have been noticed and clarified, but the many contradictory 
findings still render specific knowledge of this mechanism unclear.  Hence, 
continued research in this field is required to elucidate more evidence in order to 
illuminate this phenomenon. 
2.5.1 Effect on cytokine production 
In an in vitro study, Aldinucci & Pessina (1998) found that peripheral blood 
mononuclear cells that were exposed to 50 Hz (flux density 3 mT) fields secreted 
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increased amounts of INFγ and IL-6 after 24 hours of exposure.  This effect was 
only seen once cells had been stimulated with the mitogen, phytohaemagglutinin 
(PHA).  Cells that had not been challenged with PHA showed no increased 
release of these cytokines.  This was not demonstrated by control (sham exposed) 
samples.  They suggest a kind of “priming” event that results from exposure to 
the EMFs.  These findings support the hypothesis presented by Cuppen et al., 
2006, that ELF-EMF could boost or stimulate the immune system by “putting it 
into a state of alert due to cytokine production”. 
In a study conducted in humans, young healthy men were exposed to 50/60 Hz 
(10 µT) fields for nine hours continuously and intermittently (one hour on, one 
hour off) (Selmaoui et al., 2011).  This study was performed in a twenty-four-hour 
period for the continuous and intermittent group.  This study revealed an 
increased IL-6 in the subjects who were exposed to the intermittent field. 
2.5.2 Effect on leukocyte quantity 
Gobba et al. (2009) conducted a study in which humans were occupationally 
exposed to various levels of ELF-EMF.  The NK-cell activity was determined and 
it was found that the subjects with the highest exposure had lower NK-cell activity 
compared to subjects in the lower exposure groups.  The subjects in the lower 
exposure groups were those that were exposed to levels of 2 µT and lower, 
whereas the higher exposure groups were exposed to levels exceeding 2 µT.  
These findings are significant, since NK-cells play an important role in host 
defence against cancer.  However, further investigation in this field is needed.  
Exposure to ELF-EMF in the industrial environment is contentious, since the 
sources and duration of exposure vary considerably.  It is also difficult to identify 
the ideal control sample, since it is virtually impossible to identify a sample that 
has close to zero exposure in such environments. 
Hashish et al. (2008) found that mice exposed to 50 Hz (1.4 mT) ELF-EMF for 
thirty days had a decreased total leukocyte count, platelets, monocytes, 
peripheral lymphocytes, splenic lymphocytes, T-cells and B-cells.  There was also 
an increase in granulocyte concentration.  In addition to these findings, evidence 
of increased oxidative stress was also found.  The researchers conclude that the 
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decrease in leukocytes and platelets and the increase in granulocytes can be 
related to the increased free radical production and oxidative stress. 
2.5.3 Effect on cell activity 
It has been found that short-term exposure to fields in the ELF range affects the 
blood cell levels and results in lymphocyte proliferation (de Kleijn et al., 2011).  
Several research studies have indicated an increased phagocytic activity in 
macrophages, hence implicating an effect on the innate immune response due to 
increased free radical production (Rollwitz et al., 2004; Simko & Mattson, 2004; 
Hashish et al., 2008; Goraca et al., 2010; de Kleijn et al., 2011).  However, it was 
found that the effect of long-term exposure to ELF-EMF on the immune system 
had just the opposite effect, where it resulted in decreased blood cell levels 
(Bonhomme-Faivre et al., 2003). 
Markov et al. (2006) found striking evidence of EMFs interacting with 
lymphocytes.  They felt, however, that this interaction was strongly dependent on 
the cells‟ metabolic state.  If cells were metabolically stable, they were not 
affected by EMFs.  However, EMFs would place metabolically unstable cells 
under more stress, which lead to further instability and disequilibrium.  This then 
increased the production of free radicals, leading to oxidative stress. 
Khadir et al. (1999) investigated the effect of 22 mT fields on granulocyte activity 
and reported an increased superoxide anion (O2 / free radical) production in the 
cells that were pre-stimulated with phorbol 12-myristate 13-acetate (PMA).  They 
contributed this effect to altered intracellular signaling.  These findings agree well 
with those of Markov et al. (2006), who suggest that homeostatically unstable 
cells, but not metabolically stable cells, are affected by ELF-EMF.  This could 
possibly explain the therapeutic benefit of these fields. 
There is strong evidence that ELFs-EMFs have cell-activating capabilities.  This 
was shown by numerous authors who described an increased production of free 
radicals, which will be discussed in the following section. 
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2.5.4 Effect on release of other biologically active substances 
ELF-EMF can induce the expression of heat shock proteins which, in turn, 
provide cellular protection (Goodman & Blank, 1998).  These heat shock proteins 
are stress proteins which are released when the body experiences any stress 
influence and then reacts in a protective manner.  They are named with a prefix 
„hsp‟ followed by a number which indicates their molecular weight in kilodaltons 
(kD).  These proteins are part of a family of approximately 20 with molecular 
weights ranging from just a few kD to over 100 kD.  The major stress protein is 
hsp70 (Blank & Goodman, 2009).  Blank and Goodman (2000) explain in their 
article how the synthesis of proteins begins with the activation of DNA.  Any 
external stress factors (e.g., temperature, oxygen deprivation, dietary 
deficiencies) on the human body will result in the increased synthesis of certain 
stress proteins. They also indicate the increased synthesis of the hsp70 protein 
(also refer to Goodman and Blank, 1998) in reaction to exposure to 60 Hz EMFs 
with field strengths lower than 0.1 mT.  The increased activation of stress proteins 
results in a cellular response which is one of the body‟s natural defence 
mechanisms.  It is a cytoprotective response and when experienced for a short 
while, it will be beneficial.  Blank and Goodman (2009) refer to an experiment 
where fertilized eggs from Sciara coprophila were divided into two groups.  One 
group was pre-exposed to EMFs, after which both groups were heat shocked at 
37oC.  They found that only 10% of the unexposed eggs survived, whereas 95% 
of the eggs exposed to the EMF survived this heat shock.  They referred to this 
as “forced induction of stress proteins for stress conditioning”. 
One of the mechanisms through which ELFs-EMFs can affect biological systems, 
is through the production of free radicals (Goraca et al., 2010).  In this study it 
was found that the duration of exposure (working time) had an influence on the 
results in that longer exposure (sixty minutes vs. thirty minutes per day) resulted 
in a marked increase of ROS generation and a decrease in total antioxidant 
capacity.  An in vitro study conducted by Rollwitz et al., (2004) explains a “cell-
activating capacity of ELF-EMF” on murine bone marrow-derived promonocytes 
and macrophages.  They found that ROS production was one of the key 
processes in this phenomenon.  De Kleijn et al., (2011) cite Rollwitz (2004) in 
their publication and suggest that Rollwitz‟s study clearly demonstrated that the 
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innate immune system is affected by exposure to ELFs-EMFs through increased 
phagocytic activity and increased free radical production. 
Findings of increased free radical production and accompanied oxidative stress 
have been published by numerous authors, but not all used the same field 
strength in their studies (Simko et al., 2001 [0.5-1.5 mT]; Rollwitz et al., 2004 [1 
mT]; Simko & Mattson, 2004 [not specific – review]; Hashish et al., 2008 [1.4 mT]; 
Goraca et al., 2010 [7 mT]; Mattsson & Simko, 2012 [not specific]).  In their study, 
de Bruyn and de Jager (1994) observed stress induction using lower magnetic 
flux density (5-10 µT), but this effect was due to long-term exposure. 
2.5.5 Summarizing the effect of the Immunent signal and other ELF-EMF signals on 
the immune system 
Numerous studies have been performed using the Immunent signal.  Most of 
these studies have shown that this signal has a stimulatory effect on the immune 
system. 
2.5.5.1 The findings of Cuppen et al. (2007) 
Cuppen et al. (2007) proposed a hypothesis as to how ELFs-EMFs from the 
Immunent system (field strengths between 0.15µT - 1.5 mT and frequencies 
between 250 - 5000 Hz) can stimulate an immune response.  This response is 
stimulated when an EMF induces stress in cells which, in turn, produce cytokines.  
The production of cytokines needs some form of stimulant.  In this case, the 
stimulant is the stress production by means of EMFs through the release of 
“danger signals”.  This event alerts the immune cells to a possible action.  
Cuppen et al. (2007) suggested their hypothesis that EMFs result in the release 
of similar danger signals that are released in response to pathogens.  Figure 2.1 
illustrates their hypothesis: 
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Figure 2.3: The hypothesis by Cuppen et al. for immune activation by the EMF signal 
(After Cuppen et al., 2007) 
In two experiments on fish, this research group found a significant increase in 
ROS production of macrophages and neutrophils.  In an in vitro experiment on 
broiler chickens exposed to Coccidiodis eimeria, they demonstrated a 40% 
decrease in intestinal lesions and an 8% increase in feed conversion.  Findings 
from experiments on broiler chickens were also published by Elmusharaf et al. 
(2007). 
These studies clearly demonstrated that this signal from Immunent stimulates the 
immune response.  Their suggestion is that these EMFs have advantageous, 
practical applications in the farming industry and also hold economic benefits.  
Their study also opened the field to an area of research on the bioeffects of 
ELFs-EMFs. 
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2.5.5.2 The findings of Elmusharaf et al. (2007) 
The findings published by Elmusharaf et al. (2007) were based on similar 
experiments as those of Cuppen et al. (2007).  The published work by the former 
authors, however, only referred to the exposure of broiler chickens infected with 
coccidiosis.  Similar to the findings by Cuppen et al. (2007), there was a 40% 
decrease in intestinal lesions following thirty minute exposure per twenty four 
hours for twenty one days.  Of interest is the hypothesis proposed by Elmusharaf 
et al. (2007).  They confirmed their hypothesis that EMF inhibits an inflammatory 
reaction which, in turn, enhances an immune response.  This might sound 
contradictory, since inflammation is part of the innate immune response.  Perhaps 
the authors are implying that if the inflammatory response (which results in tissue 
damage) can be kept to a minimum and the cellular immune response can be 
enhanced, the response can be directed toward the specific pathogen and not the 
surrounding tissues. 
2.5.5.3 The findings of Keirs et al. (2005) 
Keirs et al. (2005) are cited in an article by Elmusharaf et al. (2007).  Keirs et al. 
(2005) found that exposure of commercial egg-layer hens to a specific EMF (in 
this case, not Immunent) resulted in increased egg production.  Once again, we 
see the beneficial economic implications of EMF exposure. 
2.5.5.4 The findings of de Kleijn et al. (2011) 
In an in vitro study, the above authors investigated whether ELF-EMF exposure 
with the Immunent signal had an effect on inflammatory signaling pathways.  
They found that ELF-EMF exposure had no effect on IL-6 release, early cytokine 
production or transcriptional and translational processes when stimulating cells 
with live and attenuated pathogens. 
2.5.5.5 The findings of Havas (2000) 
This author reviewed reports by the NIEHS and the US Nuclear Regulatory 
Commission (NRC).  The author reports on many other aspects of ELF-EMF 
exposure.  Concerning the immune system specifically, the author reports a lack 
of evidence that ELF-EMF affects the immune system in experimental animals. 
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2.5.5.6 The findings of Johansson (2009) 
Johansson feels very strongly that EMFs disturb the immune system by exerting 
an inflammatory response.  He/She argues that this overreaction of the immune 
system results in tissue damage.  However, this results when the duration of 
exposure is assumed to be long-term, i.e., chronic exposure.  The public‟s 
attention is therefore alerted to this being a possible cause of increased 
incidences of allergies and asthma.  He/she also postulates that this disturbance 
of the immune system could possibly predispose the individual to cancer. 
2.5.5.7 The findings of Markov et al. (2006) 
In this article the authors review and summarize findings of EMF studies on 
immune cells in an attempt to apply these EMFs therapeutically.  After reviewing 
thousands of international papers and abstracts, they were astounded by the 
diversity of the findings with respect to beneficial or hazardous effects.  They 
report a large body of evidence that short-term exposure to ELFs-EMFs 
enhances the immune system at cellular level. For example, one of the findings 
they present is that EMFs augment the intrinsic behaviour of lymphocytes.  The 
authors suggest that EMFs do not affect metabolically stable cells, but will induce 
stress in cells that are homeostatically unstable.  They consider the possibility 
that EMFs “target cells that are homeostatically unstable as a consequence of 
disease”.  If correct, this would have advantageous therapeutic implications. 
One of the major obstacles they highlight is the lack of specification of the 
physical characteristics of the signals used in the reviewed studies.  Their 
recommendation is that studies should use specific signals. 
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2.6 Summary 
We cannot escape the fact that EMFs constantly surround us.  However, it is 
important that regulations be set so that exposure levels be kept within safety 
limits.  Let us not forget that EMFs have been used as a therapeutic tool for many 
centuries, but exposure requires a specific signal, dosimetry and working time.  
To put it simply, a person cannot stand in front of the television or microwave and 
expect therapeutic results. 
It is evident that long-term exposure to ELFs-EMFs results in mild oxidative stress, 
hence promoting the inflammatory process (Mattsson & Simko, 2012).  This can 
be detrimental to human health; but according to Mattsson & Simko (2012), these 
findings need to be supported by more realistic long-term exposure experiments 
(i.e., life-long experiments). 
Although some research studies have indicated that the immune system can be 
activated by short-term exposure to ELFs-EMFs, it leaves scope for additional 
research to be conducted in this field in order to duplicate, and thus verify or 
refute, results from previous research.  In this study it meant extending the 
research to higher animals and testing additional immune parameters to those 
tested in earlier studies.  In addition to this, it was deemed beneficial to determine 
the optimal duration of exposure to obtain the desired effects.  Mattsson and 
Simko (2012) suggest that further investigations should be performed to 
determine cytokine release and threshold identification.  They also suggest 
investigating a comparison between activated cells and non-activated cells in an 
attempt to identify the mechanism of action between EMFs and cellular 
responses. 
Electricity and its generation of electromagnetic fields is part of our daily 
existence.  One can almost say that we live in an electromagnetic environment.  
This forms part of our daily existence.  Moreover, human health is largely 
dependent on the effective functioning of the body‟s immune system which is 
influenced by various factors.  If there is evidence that electromagnetic fields 
influence the immune system positively or negatively, it certainly warrants further 
investigation. 
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Lastly, following a review of numerous publications on the effect that the 
Immunent Activator signal has on the immune system, it became evident that 
there are growing indications that this signal has a stimulatory effect on the 
immune system.  Hence, the therapeutic application and commercial value of this 
signal holds many advantages and should be investigated. 
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CHAPTER 3 
METHODOLOGY 
3.1 Introduction 
The study involved causal-comparative (ex post facto) research where 
experimental mice were treated with the Immunent signal and control mice 
received no (sham) exposure.  The findings among the exposed (experimental) 
mice were then compared, and the results were also compared with those of the 
control mice.  
Three groups of mice were exposed to an Immunent BV ELF-EMF signal with an 
intensity of 5 µT for seven days.  Each group was exposed to this EMF signal for 
a different length of time per day.  Simultaneously, a control group of mice was 
kept in a separate room under identical conditions, with the exception of EMF 
exposure (sham exposure).  After seven days, following completion of the 
exposure period, all the mice from the three groups were anaesthetized, whole 
blood was collected and the mice were sacrificed.  The whole blood was used for 
full blood count (FBC) and immunophenotyping analysis.  Results for all the 
parameters measured were captured on an excel spreadsheet and statistically 
analyzed. 
The results of the exposure groups were compared with those of the control 
group to determine whether there was a statistically significant difference 
between the control and the exposure groups.  In addition to this, the three 
exposure groups were compared to one another to determine whether the 
duration of exposure had any influence on the results.  Figure 3.1 provides a 
schematic layout of the exposure protocol and laboratory analysis. 
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Figure 3.1: Schematic summary of research methodology 
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3.2 Materials and apparatus 
While the exposure of the animals took place at an experimental animal facility, 
the biological analyses were performed in a laboratory.  The materials and 
apparatus used in the experiment are described and discussed in this section.  
These include the experimental animals, their housing, the exposure system and 
the biological laboratory analyses. 
3.2.1 Exposure system 
The exposure system consisted of the Immunent Activator signal, cylinders and 
housing, each of which are described below.  The generator created the specific 
Immunent Activator signal which was wired to the cylinders.  The cylinders were 
designed to hold the housing cages with the mice for the exposure period. 
3.2.1.1 Exposure system signal 
Figure 3.2 below depicts the control box containing the generator for the 
exposure system used in the study.  The generator was patented and supplied by 
Immunent BV (Werfberg 12, Veldhoven, The Netherlands). 
 
Figure 3.2: Immunent (IM) signal source 
The signal generated by Immunent (IM) BV is a specific signal consisting of 
multiple waveforms creating complex, continuously changing electromagnetic 
fields (EMFs) with steep rise times and exponential decays as illustrated in Figure 
3.3.  The Immunent exposure system uniformly exposed the experimental group 
of mice to EMFs (multiple frequencies between 20 - 5000 Hz) with an intensity of 
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5 µT.  At these low exposure settings, there was no chance of heat or sound 
generation.  A computerized time switch was installed to regulate the various 
exposure durations. 
 
Figure 3.3: Illustration of signal 
3.2.1.2 Exposure cylinders 
Custom-made plastic cylinders were constructed to house the cages containing 
the mice while they were exposed to the signal.  The cylinders were fixed onto 
wooden tables inside the experimental room (Figure 3.4).  Copper coils were 
wound around each cylinder to create the electromagnetic field controlled from 
the Immunent exposure control system.  The dimensions of the cylinders were 20 
cm in diameter with a length of 120 cm.  These dimensions allowed up to three 
levels of cages within the cylinders.  Holes were drilled into the cylinders to permit 
good ventilation and light inside the cylinders.  Figure 3.4 illustrates the cylinders 
that had been constructed. 
0 1 2 3 4 5 6
Time [ms] 
Immunent Signal for coil with R = 400 L 
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Figure 3.4: Exposure cylinders 
3.2.2 Experimental animals 
Mice (Mus. musculus) were used for the study.  The animals were supplied by the 
University of the Free State (UFS) Animal Unit.  This specific strain of mice is 
bred at the animal unit under controlled conditions for experimental use.  The 
sample of experimental animals consisted of one hundred healthy young adult 
(approximately six weeks old) male mice of the BALB/c N1H strain.  The mean 
weight of the mice was 23+/-1.5 grams.  The weight was kept within this range for 
all the mice to avoid dominant behaviour by larger mice. 
 
Figure 3.5: Mice (Mus. Musculus) BALB/c N1H strain 
3.2.3 Housing and facility 
The experiment was conducted at the UFS Animal Unit facility.  Both the 
experimental and the control room were approximately three meters by seven 
meters in size.  The experimental room was equipped with twelve tables 
containing fixed exposure cylinders (Figure 3.6) and the control room was 
equipped with four tables containing fixed cylinders.  For the housing of the 
animals, specifically designed cages were custom made with depth x breadth x 
EMF Source wire 
Holes 
Levels for cages 
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length (DxBxL) dimensions of 15x15x30 cm.  These cages could comfortably 
accommodate three to four mice each.  The cages were made of hard plastic with 
a layer of absorbent saw dust on the floor of the cage.  The top of the cage was 
covered with a perspex lid containing sufficient ventilation holes.  The lid was 
designed in such a way that the water bottle nozzle could fit into it, facing towards 
the inside.  Glass tubes supplied slits large enough for food to be reached and 
nibbled by the mice, but also small enough that the mice were not able to escape.  
The use of steel in the cages was avoided to eliminate the possibility of 
interactions between steel and the EMFs. 
 
Figure 3.6: Housing cage with feeder 
3.2.4 Experiment setup 
The experiment was set up to comprise of four groups of mice.  Each group 
consisted of four cylinders containing two cages each.  Each cage housed three 
mice, with one of the cages in the fourth cylinder housing four mice, giving a total 
of twenty five mice per group.  Each group received a different duration of 
exposure. 
Water bottle 
Ventilation holes 
Feeder 
Sawdust 
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Figure 3.7: Experiment (exposure) room setup 
The four cylinders for the control group were kept in a separate room where there 
was no exposure to EMFs.  In all other aspects, the control group was treated in 
the same way as the experimental group. 
 
Figure 3.8: Control room setup 
Equipment and materials used for the exposure protocol are included in Table 3.1.  
Some of the equipment used had to be custom made to fit into the room and to 
comply with the requirements of the study, but where possible, the animal unit 
supplied most of the equipment and material. 
  
Cylinder 
Cage 
Table 
Cylinder 
Table 
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Table 3.1: Animals, housing equipment and material used for exposure 
procedure 
EQUIPMENT / 
APPARATUS 
SOURCE DESCRIPTION 
Mice (Mus. musculus) Animal Unit, UFS BALB/c N1H strain 
Housing cages Custom-made Dimension (DxBxL): 
15x15x30 cm 
Signal source Immunent (IM) Werfberg 12, Veldhoven, The 
Netherlands 
Exposure cylinders  Custom-made 20 cm diameter, 120 cm long 
Exposure room Animal Unit, UFS 300 cmx800 cm 
Control room Animal Unit, UFS 300 cmx800 cm 
Food Animal Unit, UFS EPOL balanced mouse 
pellets 
 
3.2.5 Biological Analysis 
The biological parameters measured were performed on whole blood obtained 
from the mice.  Approximately 1 ml whole blood was collected in blood tubes 
containing ethylenediaminetetraacetic acid (EDTA) powder.  Haematological 
parameters measured included the full blood count and immunophenotyping of 
lymphocyte subsets. 
3.2.5.1 Full blood count 
An ABX Pentra 60C+ analyzer was used to measure the full blood count (FBC) 
parameters.  The analyzer is able to determine the type and size of all the cells 
and haemoglobin concentration contained in blood.  The data were transferred to 
a computer with compatible software and then printed.  The reagents and 
controls used were compatible with the specific analyzer. 
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(Horiba ABX Pentra C60+ Haematology Analyzer, 
online) 
Figure 3.9: Pentra 60C+ analyzer 
Equipment and reagents used for the FBC are presented in Table 3.2.  Suppliers 
and model / brand of the reagent and / or equipment are also included in the table. 
 
Table 3.2: Equipment and reagents for full blood count 
APPARATUS / REAGENTS SUPPLIER MODEL / CODE 
Full blood count analyzer Horiba, Japan Pentra 60C+ Analyzer 
LYSEBIO Scientific Group ABX/0906013 
BASOLYSE 1L PENTRA 60 Scientific Group ABX/0906003 
CLEANER 1L PENTRA 60 Scientific Group ABX/0903010 
DILUENT 20L PENTA 60 Scientific Group ABX/0901020 
EOSINOFIX 1L PENTRA 60 Scientific Group ABX/0206010 
DIFFTROL  NORMAL 
Control 
Scientific Group ABX/2062203 
DIFFTROL LOW Control Scientific Group ABX/2062207 
DIFFTROL HIGH Control Scientific Group ABX/2062208 
 
3.2.5.2 Immunophenotyping 
All reagents used were of research quality and obtained from a reputable firm.  
The antibody markers were specific for mice (rat-anti-mouse).  A control was 
included for each specific antibody isotype and fluorescent marker.  Analyses 
were performed on a Flourescence activated cell sorting (FACS) Calibur analyzer 
(Becton Dickinsin).  The reagents, controls and instrumentation used for the 
immunophenotyping are presented in Table 3.3. 
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Table 3.3: Equipment and reagents for immunophenotyping 
APPARATUS / REAGENTS SUPPLIER MODEL / CODE 
Immunophenotyping analyzer UFS Haematology 
(Becton Dickinsin) 
FACS Calibur 
CD3 FITC / IgG2a Beckman Coulter 731992 
CD4 PE / IgG2b Beckman Coulter 733259 
CD8 PE / IgG2a Beckman Coulter 733264 
CD19 FITC / IgG2a Beckman Coulter 732058 
Mouse IgG2a FITC Control Beckman Coulter A12690 
Mouse IgG2a PE Control Beckman Coulter A09141 
Mouse IgG2b PE (clone A-1) 
Control 
Beckman Coulter 731601 
 
  
 51 
 
3.3 Methods 
The methods involved four processes: 
 exposure of the animals to the EMF  
 the bleeding and sacrificing of the animals  
 laboratory testing  
 data capturing / processing for statistical analyses. 
The methods had been planned well in advance to ensure fluent and efficient 
flow of procedures.  After the exposure had been completed, analyses were 
performed on the same day as bleeding / sampling.  Good laboratory practice 
and procedures were adhered to, ensuring quality control and accuracy 
throughout all procedures.  The rules and regulations of the South African 
National Standards (SANS) (SANS 10386:2008 The care and use of animals 
for scientific purposes and guidelines on ethics for medical research) were 
strictly adhered to. 
3.3.1 Ethical aspects 
Approval for the study was granted (No. 20/08) by the interfaculty animal ethics 
committee of the UFS (Appendix 1).  Guidelines for the welfare of experimental 
animals were strictly adhered to according to the Experimental Animal Act (South 
African veterinary Foundation, online).  These guidelines could be followed with 
the assistance of the personnel at the animal unit of the UFS, since the personnel 
at this unit had been trained and were qualified to work with experimental animals. 
3.3.2 Experimental animals 
Once the mice were received, they were checked for any defects and it was 
confirmed that all the mice were in good health.  The sample of mice was divided 
into four groups of twenty five each. Three groups served as the experimental 
(exposure) groups, which were to be exposed to the Immunent signal.  The fourth 
group served as a control and received sham (no) exposure. 
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3.3.3 Exposure protocol 
The exposure protocol consisted of three groups with four cylinders per group 
(Figure 3.10).  Group A was exposed to the Immunent signal continuously (24 
hours), group B was exposed for four hours per day and group C was exposed 
for one hour per day.  Each cylinder had two levels (one cage per level) with 
three mice per cage, with the last cage of each group housing four mice.  These 
numbers mounted to a total of 25 mice per group.  The control group was kept in 
a separate room under identical conditions as the experimental exposure group, 
with the exception of EMF exposure.  Exposure was administered for seven days.  
Daily visits were made to the facility to check on the mice with respect to feed, 
water, room temperature and the exposure system.  During daily feeding times, 
the cages were rotated on the levels to ensure equal amount of signal, light 
exposure and oxygen for all the mice. 
 
Figure 3.10: Schematic representation of exposure protocol 
  
Exposure Protocol 
Control Group 25 
mice 
No exposure Experimental 
Group - 75 mice 5 
µT exposure for 7 
days 
Group A 
continuous 
exposure - 25 
mice 
Group B - 4 hours 
exposure per day 
- 25 mice 
Group C - 1 hour 
exposure per day 
- 25 mice 
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3.3.4 Housing and exposure 
The exposure system supplied the EMF signal to each cylinder which housed two 
cages per cylinder.  Three to four mice were housed in each cage.  The cages 
were lined with a two centimeter layer of sawdust for bedding and absorbance of 
urinary excretions. The mice were provided with constant access to food and 
water.  The mouse diet consisted of Epol balanced mouse pellets, supplied by the 
UFS animal unit.  Visits were made daily to the facility to check on food and water.  
During these visits the cages in each cylinder were alternated to ensure equal 
exposure of light and EMFs.  Cages were identified with a card indicating the 
cage number and initial weight of each mouse.  Controlled environmental 
conditions were adhered to, with constant room temperature of 21oC and light 
switches controlling a twelve-hour day and a twelve-hour night routine.  Human 
handling of the mice was kept to a minimum to prevent induction of stress in the 
animals. 
 
Figure 3.11: Cages were rotated on a daily basis 
3.3.5 Sample collection and preparation 
The sample collection and preparation were carried out over three days, since it 
was not possible to attend to the entire sample in one day.  On the first day, 30 
samples were prepared and analyzed and 35 were completed on each of the 
second and third days. 
After completion of seven days of exposure, the mice were transferred to a 
theatre room at the animal unit which is specially equipped for the bleeding 
procedures that were to be performed.  Taking one cage from each group at a 
Cylinder 
Cage level 
Cage with mice 
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time, the mice were transferred from their cages to an anaesthetic chamber 
containing Allantoin gas.  Once fully anaesthetized, approximately 1 ml whole 
blood was collected from each mouse by means of orbital bleeding.  The bleeding, 
anaesthetics and sacrificing were performed by trained personnel at the animal 
unit.  Whole blood was collected into marked / numbered 5 ml blood tubes 
containing EDTA (powder) anticoagulant for full blood count and 
immunophenotyping.  Whole blood was immediately re-suspended in the 
anticoagulant to prevent clotting of blood.  While still anesthetized, the mice were 
sacrificed by cervical dislocation. 
Once the blood was properly mixed, equal amounts of blood were transferred to 
two separate eppendorf tubes.  A 500 µl aliquot was used for the full blood count 
and a 500 µl aliquot was used for the immunophenotyping. 
3.3.6 Full Blood Count 
The 500 µl aliquot whole blood samples were transported at room temperature to 
the Haematology laboratory.  Upon arrival at the laboratory, the blood tubes were 
placed on a roller to keep the blood mixed until the analyses were performed.  
Full blood analyses were performed within one hour of reaching the laboratory 
using a Pentra 60 C+ (from ABX Diagnostics) analyzer and the results were 
printed.  The analyses were done within several hours of blood collection.  A 
minimum of 200 µl whole blood (EDTA) was required for these analyses. 
The parameters measured included white blood cell count (WBC), red blood cell 
count (RBC), haemoglobin concentration (Hb), haematocrit (Hct), mean 
corpuscular volume (MCV) and platelet count (Plt).  Lymphocyte, monocyte, 
neutrophil, eosinophil and basophil differential counts were also determined. 
Controls included high, low and normal controls, as well as interlaboratory control 
run in collaboration with the National Health Laboratory Services (NHLS) 
Haematology laboratory as an additional control. 
3.3.7 Immunophenotyping 
The other 500 µl aliquots of whole blood were transported at room temperature to 
the Haematology laboratory at UFS where the immunophenotyping was 
performed that same day.  Immunophenotyping involves identification of specific 
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antigens on lymphocyte surface, known as cluster of differentiation (CD), in order 
to define the specific lymphocyte subtype.  Aliquots of 100 µl whole blood with 
EDTA anticoagulant were placed into marked tubes for CD3, CD4, CD8 and 
CD19.  10 µl Specific fluorescent antibody markers (rat anti-mouse) were added 
to whole blood and incubated to facilitate binding of antibodies to specific 
antigens.  Red blood cells were lysed with a FACS lysing solution and a 
stabilizing solution was added to the marked cells.  Results were analyzed on a 
FACS Calibur analyzer (Becton Dickinsin) to sort and count the specific 
lymphocyte populations.  Isotype-specific controls were run for each marker.  
Result printouts were filed as hard copies. 
3.3.8 Quality Control 
Good laboratory practice (GLP) standards were conformed to, with quality control 
procedures and the necessary controls implemented where necessary.  Prior to 
the study, a validation process of the entire study was run to ensure effective flow 
of the work and that all procedures were feasible.  Fluency was critical, since the 
number of procedures and samples was extremely time-consuming and had to be 
precisely planned. 
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3.4 Data Collection and Statistical Analyses 
Printed copies of the results for FBC and immunophenotyping analysis were 
collected and, once all data had been captured, the hard copies were filed for 
future reference.  This section will explain how the raw data were captured and it 
will also illuminate the statistical analyses that were performed. 
3.4.1 Data collection 
Raw data were compiled onto an excel worksheet and included (Appendix 2).  
The raw data included all the parameters measured in the FBC as well as the 
immunophenotyping values.  Parameters were expressed in their specific units of 
measurement. 
3.4.2 Statistical analyses 
The raw data were analyzed by a statistics consultant (Maryn Viljoen, Statistics 
Consulting Services) for analyses.  Descriptive statistics namely means and 
standard deviations (or medians and percentiles) were calculated for each of the 
three exposure groups and the control group. 
The mean or median values of each of the exposure groups were compared 
individually to the mean or median values of the control group using either the t-
test or Kruskal-Wallis Test for independent samples. Where the results did not 
give a well distributed curve, the median values were used, but where a well 
distributed curve was obtained, the mean values were used.  A significance level 
of 0.05 was used. The ANOVA test or Kruskal-Wallis Test was used to determine 
statistically significant mean or median differences (p<0.05) of the exposure 
groups (A = continuous exposure, B = four hours, C = one hour) amongst 
themselves.  The Kruskal Wallis test was used for median values.  Any outliers 
and clotted samples were excluded from the statistical analyses. 
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3.5 Conclusion 
In summary, the methodology involved exposing mice to a specific Immunent 
ELF-EMF signal for a short period of time (seven days).  The experimental group 
consisted of three groups of mice which were exposed to the EMF signal for 
different lengths of time.  The control group was kept away from any source of 
EMF, but in all other aspects it was treated in the same way as the experimental 
group.  Interference with the social behaviour of the mice was kept to a minimum 
in an attempt to prevent stress in the mice. 
Ethical aspects with respect to the treatment of the experimental animals were 
strictly adhered to (SANS 10386:2008).  This was made possible with the help of 
qualified personnel at the UFS animal unit. 
After seven days, the mice were anaesthetized and bled. The blood was sent for 
biological analyses. The results were captured on an excel worksheet and sent 
for statistical analyses.  A complete layout of the research protocol and a 
discussion of the results follow in Chapter 4.  
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CHAPTER 4 
RESULTS AND DISCUSSION 
4.1 Introduction 
For this comparative study, the results of the EMF-exposed groups were 
compared with the sham-exposed (control) group.  The results of the exposure 
groups were compared with those of one another as well as with those of the 
control group to determine if any statistically significant differences existed.  In 
addition to this, the results of the various exposure groups were compared with 
each other for statistically significant differences.  As stated in section 3.4.2, 
where the results did not give a well distributed curve, the median values were 
used, but where a well distributed curve was obtained, the mean values were 
used.  Outlier values were excluded from the statistical analyses. 
For the presentation of the results, the exposure and control groups are referred 
to as follows: 
 Continuous exposure group (24 hours) - Group A 
 Four-hour exposure group - Group B 
 One-hour exposure group - Group C  
 Control group - Group K 
Figure 4.1 presents a diagrammatic summary of the experiment and the 
parameters according to which the results are discussed in this chapter. 
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Figure 4.1: Schematic summary of presentation of results 
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4.2 Experimental rollout and facility 
During the daily visits to the facility a close inspection of the exposure system, 
room temperature, housing, feeding, behaviour and condition of the mice was 
done.  An exposure worksheet was created to record the significant findings. 
4.2.1 Exposure system 
The exposure system functioned without interruption.  A computer program 
connected to the exposure system to monitor the exposure times indicated no 
evidence of error during the exposure period.  No power failures were reported by 
the personnel of the experimental animal facility.  Thus, it could be deduced that 
the exposure protocol was completed successfully. 
4.2.2 Housing and facility 
All aspects of the housing were found to be in good order.  The room temperature 
measured constantly between 21-22oC.  With the doors permanently closed, 
unnecessary noise was also filtered from the room.  The only people that entered 
the rooms were the researchers involved with the study.  This also lessened the 
likelihood of the mice being exposed to foreign scent. 
4.2.3 Experimental animals 
The BALB/c N1H strain mouse specie was chosen due to their small size.  This 
made it possible for a large enough number of mice (one hundred) to be housed 
comfortably in the space available at the Animal Unit facility.  From previous 
experiments, a sample of one hundred mice was found to be sufficient.  The 
maximum number of mice that could be completed in one day from bleeding to 
completion of all tests was thirty five. 
At the age of six weeks, the mice had reached sexual maturity and were 
considered young, but fully grown.  Male mice were selected for the study to 
exclude sexual hormonal interference as would have been the case in female 
mice. 
There were no significant behavioural changes in the mice during the exposure 
period.  The mice fed well and, evidently, appeared to experience minimal stress 
throughout the experiment.  The animals appeared to be comfortable with the 
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housing, feed and bedding provided.  Likewise, the control mice also appeared to 
be comfortable and fed well during the trial period.  No differences were noted 
between the behaviour of the experimental and the control animals. 
The animals were handled with extreme care during the anaesthesia period.  The 
practice of limiting the handling and feeding of the animals to one (at most two) 
persons would have contributed minimizing stress in the animals. 
The entire sample of one hundred mice were bled and sacrificed for the study.  
However, a small number of the collected blood samples could not be used for 
analysis due to clotting of blood when collection time was prolonged.  The 
bleeding process proved to be challenging in the sense that the blood often 
began to clot before the bleeding process was complete.  Administering heparin 
to the animals prior to the bleeding could moderately decrease this problem, but 
then there was the possibility of placing the animals under stress due to handling, 
since heparin needs to be administered by injection.  For this reason it was 
decided against heparin administration prior to bleeding of the animals. 
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4.3 Biological analyses  
The biological analyses included the full blood count (FBC) and 
immunophenotyping on whole blood collected in EDTA.  Each group of biological 
parameters was recorded in a table, after which each parameter was represented 
graphically.  This was done for the exposure groups vs. the control as well as for 
the intergroup comparisons.  The results for each parameter were depicted in a 
table where the data included the mean / median, standard deviation (SD) as well 
as the p-value for the t-test / Kruskall-Wallis test of each exposure group 
compared to that of the control group.  Following each table presenting the data, 
are figures with histograms presenting a diagrammatic representation of each set 
of data.  SD error bars and trend lines were included. 
4.3.1 Full blood count 
The presentation of the results for the FBC was grouped into erythrocyte 
parameters, platelet counts and leukocyte parameters.  The parameters of most 
significance for this study were those of the leukocytes, since these cells are 
involved in the immune response and are also known as immune cells (Delves, 
Martin, Burton & Roitt, 2011:35).  Hence, the specific differential leukocyte counts 
were determined and either shown to have statistical significant relevance with 
respect to the immune response, or shown to present no relevance at all. 
4.3.1.1 Red blood cell (erythrocyte) parameters 
The descriptive statistics and statistical significance for differences between the 
experimental groups (A, B and C) and the control group for the erythrocyte 
parameters are depicted in Table 4.1.  The erythrocyte parameters, and their 
units of measurement, included the following: 
 Erythrocyte count, expressed as 1012 erythrocytes per litre (1012/L) whole 
blood. 
 Haemoglobin (Hb), expressed as grams per decilitre (g/dl) whole blood. 
 Haematocrit (Hct), expressed as percentage (%) whole blood. 
 Mean corpuscular volume (MCV), expressed as femtolitre (fl) whole blood. 
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Table 4.1: Descriptive statistics and p-values for mean / median 
erythrocyte parameters 
Parameter  A B C K 
Erythrocyte 
count 
Mean (1012/L) 9.32 9.26 9.21 9.23 
SD 0.28 0.53 0.52 0.49 
p-value t-test 0.4748 0.8340 0.8833  
Hb 
Mean (g/dl) 14.76 14.76 14.66 14.75 
SD 0.51 0.71 0.79 0.64 
p-value t-test 0.9327 0.9419 0.6795  
Hct 
Mean (%) 44.12 43.88 43.86 43.72 
SD 1.37 2.6 2.45 2.33 
p-value t-test 0.4713 0.8271 0.8441  
MCV 
Median (fl) 47.00 47.00 47.00 47.00 
Inter-quartile range 47.00-48.00 47.00-48.00 47.00-48.00 47.00-48.00 
p-value Kruskal-
Wallis Test 
0.2422 0.8513 0.0688  
(p<0.05 indicates statistically significant difference) 
 
Figures 4.2 (a – d) depict the comparative mean / median values for the 
parameters in Table 4.1.  Histograms were used to depict the values for the three 
different exposure groups and the control group. 
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Figure 4.2 (a): Mean / median values for erythrocyte count of all the groups 
 
The trend line showed a slight decrease in erythrocyte values from group A to 
group C.  In spite of this slight trend, there were no statistically significant 
differences between the EMF exposure groups and the control group (Figure 
4.2a). 
 
 
Figure 4.2 (b): Mean values for Hb concentration of all the groups 
 
There were no statistically significant differences for Hb levels between the 
exposed groups and the control group.  There was also absence of a trend in this 
regard (Figure 4.2b). 
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Figure 4.2 (c): Mean values for Hct of all the groups 
 
Once again, there was a slight trend indicating increasing Hct values as the 
exposure duration increased.  However, the differences were not statistically 
significant (Figure 4.2c). 
 
 
Figure 4.2 (d): Median values for MCV of all the groups 
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There were no statistically significant differences between the exposed groups 
and the control group.  The spike of increased values for group C was, therefore, 
not statistically significant (Figure 4.2d). 
 
4.3.1.1.1 Summary of comparative mean / median values for the erythrocyte 
parameters 
To summarize, there were no statistically significant differences between the 
exposure groups and the control group for any of the erythrocyte parameters.  
The p-values for the t-test and the Kruskal-Wallis Test were found to be above 
the statistically significance indicator of 0.05 (p>0.05). 
 
Table 4.2 below represents the p-values of mean / median differences for 
erythrocyte parameters between all the groups (ANOVA test or Kruskal-Wallis 
Test) and between the individual groups (intergroup comparison). 
 
Table 4.2: Intergroup comparison for mean / median erythrocyte 
parameters 
Parameter 
A vs. B vs. C (ANOVA 
t-test / Kruskal-Wallis 
Test) 
p-value 
A vs. B (t-test / 
Kruskal-Wallis 
Test) 
p-value 
A vs. C (t-test / 
Kruskal-Wallis 
Test) 
p-value 
B vs. C (t-test / 
Kruskal-Wallis 
Test) 
p-value 
Erythrocyte 0.7267 0.6672 0.3868 0.7281 
Hb 0.8355 1.0000 0.5988 0.6392 
Hct 0.8957 0.6810 0.6416 0.9778 
MCV 0.2256 0.3244 0.4146 0.0954 
(p<0.05 indicates statistically significant difference) 
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Figures 4.3 (a - d) depict the graphics for the mean / median intergroup 
comparison of the erythrocyte parameters.  The histograms depict the 
comparison of each group with the other. 
 
Figure 4.3 (a): Intergroup comparison of mean erythrocyte count 
 
Although the largest difference found was between groups A and C for the 
erythrocyte count, the difference was not statistically significant.  There were no 
statistically significant differences between any of the exposure groups for the 
erythrocyte counts (Figure 4.3a) 
 
 
Figure 4.3 (b): Intergroup comparison of mean Hb concentration 
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As with the erythrocytes, there were no statistically significant differences 
between any of the exposure groups for the Hb concentration.  All the values 
were very similar (Figure 4.3b). 
 
Figure 4.3 (c): Intergroup comparison of mean Hct percentage 
 
There was a slight variation in Hct concentration between groups A and B as well 
as between groups B and C, but it was not statistically significant.  No statistically 
significant differences for the intergroup comparisons were found between any of 
the exposure groups (Figure 4.3c). 
 
 
Figure 4.3 (d): Intergroup comparison of median MCV concentration 
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The intergroup comparison (data in Table 4.2 and Figures 4.3 (a - d) indicated no 
statistically significant mean or median differences between the exposure groups 
for any of the erythrocyte parameters (p<0.05).  The ANOVA test / Kruskal-Wallis 
Test (A vs. B vs. C) showed no statistically significant mean or median 
differences (p>0.05) for any of the erythrocyte parameters. 
4.3.1.1.2 Summary of intergroup comparisons for mean / median erythrocyte 
parameters 
To conclude this group of analyses, the erythrocyte parameters in FBC indicated 
no statistically significant differences between any of the groups (A, B, and C) 
and the control group.  In addition, there was no statistically significant difference 
in erythrocyte parameters for the intergroup comparison.  In spite of the lack of 
statistically significant differences, there was a general trend for higher 
erythrocyte values in group A, and to a lesser extent, also group B. It can 
therefore be deduced that exposure to the ELF-EMF had no effect on the 
erythrocyte parameters of the mice.  The duration of exposure (twenty four, four 
and one hours) also had no effect on the results of the erythrocyte parameters. 
4.3.1.1.3 Discussion of findings for erythrocyte parameters 
Evidently, in the current study there was no anticipation that the ELF-EMF would 
have any effect on the erythrocytes, since the immune system involves 
predominantly the leukocytes (Coico & Sunshine, 2009:11-25). 
In a study where rabbits were exposed to radiofrequency EMFs, their erythrocyte 
parameters did not differ from those of the control group (Sarookhani et al., 2012).  
However, the fields in the study by Sarookhani et al. (2012) were stronger (950M 
Hz) than those in the current study.  In another study where the EMFs were 
similar to those used in the current study, it was also found that there were no 
statistically significant differences in erythrocyte parameters between the exposed 
groups and the control group (Cakir et al., 2009).  This study differed from the 
current study in the sense that exposure took place over a longer period (fifty and 
one hundred days). 
El-Bialy et al. (2012) conducted a study in which rats were exposed to ELF-EMFs 
for an extended period (thirty days).  They found that erythrocyte, Hb and Hct 
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levels were decreased in the exposed group.  However, no significant difference 
was found in this study.  
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4.3.1.2 Platelet count 
The descriptive statistics and significance for median differences between the 
experimental groups (A, B and C) and the control group for the platelet count are 
depicted in the Table 4.3.  The platelet count was expressed as 103/mm3 whole 
blood. 
Table 4.3: Descriptive statistics and p-values for median platelet count 
Parameter  A B C K 
Platelets 
Median(103/mm3) 854.00 879.00 890.00 828.00 
Inter-quartile range 
785.00-
932.00 
783.00-945.00 
775.00-
1029.00 
761.00-
1028 
p-value Kruskal-
Wallis Test 
0.9045 0.9362 0.6672  
(p<0.05 indicates statistically significant difference) 
 
The histogram below (Figure 4.4) facilitates a graphic view and representation of 
the median values in Table 4.3. 
 
 
Figure 4.4: Median platelet count of all the groups 
From Figure 4.4 it is evident that the platelet count increased as the exposure 
period decreased.  The control value was lower than the values of the three ELF-
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EMF-exposed groups.  However, none of the differences were statistically 
significant. 
4.3.1.2.1 Summary of comparative median values for the platelet parameters 
There were no statistically significant differences (p>0.05) between any of the 
exposure groups and the control group for the platelet count.  This was found with 
reference to the descriptive statistics and significance for median differences 
between the experimental groups (A, B and C) and the control group as depicted 
in Table 4.3. 
Table 4.4 below indicates the p-values for median differences in platelet counts 
between all the groups (using the Kruskal-WallisTest) and between the individual 
groups (intergroup comparison). 
Table 4.4: Intergroup comparison for median platelet count 
Parameter 
A vs. B vs. C 
(Kruskal-Wallis Test) 
p-value 
A vs. B (Kruskal-
Wallis Test) 
p-value 
A vs. C (Kruskal-
Wallis Test) 
p-value 
B vs. C (Kruskal-
Wallis Test) 
p-value 
Platelets 0.6334 0.7859 0.3986 0.4434 
(p<0.05 indicates statistically significant difference) 
A graphic view and representation of the median intergroup comparison can be 
seen in the histogram below (Figure 4.5): 
 
Figure 4.5: Intergroup comparison of median platelet counts 
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Although there appeared to be a marked difference between groups A and B, it 
was not statistically significant.  The difference between groups A and C was 
even more prominent, yet it was not statistically significant either. 
4.3.1.2.2 Summary of intergroup comparison for median platelet parameters 
For the intergroup comparison, there were no statistically significant median 
differences (p>0.05) between any of the exposure groups themselves (A, B or C) 
for the platelet counts.  The Kruskal-Wallis Test (A vs. B vs. C) also indicated no 
statistically significant differences (p>0.05) between the groups. 
4.3.1.2.3 Discussion of findings for platelet parameters 
It was clear that ELF-EMF exposure did not have any effect on the peripheral 
platelet counts of the experimental mice.  The duration of exposure also had no 
effect on the platelet count. 
The study by Sarookhani et al. (2012) produced different results.  They exposed 
rabbits to mobile phone radiation with a frequency of 950 Mhz (3 and 6 Watts).  In 
the 3 Watt group, the platelet counts were decreased, but the counts were 
increased in the 6 Watt group.  However, these results have no direct bearing on 
the current study since the frequency of the fields was much higher than in the 
current study (50-5000 Hz).  The results of the study by Cakir et al. (2009) on 
platelets concur with those of the current study, whereas the platelet counts in a 
study by El-Bialy et al. (2012) were found to be statistically significantly increased 
in the exposed group.  However, the exposure period in the latter study, was 
thirty days compared to the seven days of the current study. 
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4.3.1.3 Leukocyte parameters 
The descriptive statistics and statistical significance for mean or median 
differences between the experimental groups and the control group for the 
leukocyte parameters are depicted in Table 4.5.  Where statistically significant 
differences were found, the value is highlighted in the table.  An asterix (*) is 
assigned to the column of the graph in Figures 4.6 (a - f) where a statistically 
significant difference was found. The leukocyte parameters and their units of 
measurement were the following: 
 The total leukocyte count, expressed as 109 leukocyte per litre (109 /L) 
whole blood.  This count included all the leukocyte counts below. 
 The lymphocyte count, expressed as a percentage of the total leukocytes. 
 The monocyte count, expressed as a percentage of the total leukocytes. 
 The neutrophil count, expressed as a percentage of the total leukocytes. 
 The eosinophil count, expressed as a percentage of the total leukocytes. 
 The basophil count, expressed as a percentage of the total leukocytes. 
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Table 4.5: Descriptive statistics and p-values for mean / median 
leukocyte parameters 
Parameter  A B C K 
Total 
Leukocytes 
Mean (109 /L) 7.26 7.06 6.66 6.33 
SD 1.66 1.44 1.42 1.39 
p-value t-test 0.0391 0.0773 0.4032  
Lymphocytes 
Median (%) 89.25 87.30 87.10 87.10 
Inter-quartile range 87.3-92.55 85.60-90.90 85.50-89.20 84.25-89.05 
p-value Kruskal-
Wallis Test 
0.0149 0.4715 0.5555  
Monocytes 
Median (%) 2.60 3.00 3.10 3.25 
Inter-quartile range 1.70-3.60 2.30-3.80 2.20-4.10 2.50-4.90 
p-value Kruskal-
Wallis Test 
0.0833 0.5549 0.6309  
Neutrophils 
Median (%) 6.50 8.60 8.70 9.00 
Inter-quartile range 5.60-8.70 6.90-10.10 7.20-10.20 7.80-9.85 
p-value Kruskal-
Wallis Test 
0.0014 0.2712 0.6169  
Eosinophils 
Median (%) 0.10 0.20 0.20 0.20 
Inter-quartile range 0.10-0.20 0.10-0.30 0.10-0.40 0.10-0.40 
p-value Kruskal-
Wallis Test 
0.1360 0.9030 0.8469  
Basophils 
Median (%) 0.40 0.40 0.40 0.40 
Inter-quartile range 0.30-0.50 0.30-0.50 0.30-0.40 0.30-0.50 
p-value Kruskal-
Wallis Test 
0.6656 0.8356 0.2562  
(p<0.05 indicates a statistically significant difference) 
The histograms below (Figures 4.6 a – f) represent the data in Table 4.5.  A 
separate graph was created for each specific parameter, in spite of the fact that 
several units of measurement were the same.  This was to simplify visualization 
of the group results compared to those of the control. 
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Figure 4.6 (a): Mean values for the total leukocyte count of all the groups 
* = Statistically significant difference (p<0.05) 
Figure 4.6a shows a statistically significant difference in leukocyte count between 
group A and the control group.  There was no statistically significant difference 
between groups B, C and the control group.  The trend line showed a decrease in 
leukocyte count as the exposure duration decreased, being statistically significant 
only in group A. 
 
Figure 4.6 (b): Mean values for the total lymphocyte percentage of all the groups 
* = Statistically significant difference (p<0.05) 
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From Figure 4.6b it is evident that there was a statistically significant difference 
between group A and the control group for the lymphocyte count.  There was no 
evidence of any differences between groups B, C and the control group. 
 
Figure 4.6 (c): Median values for the monocyte percentage of all the groups 
The trend line in Figure 4.6c indicated a gradual increase in monocyte 
percentage as the duration of exposure decreased.  Exposure group A (24-hour 
exposure) had the lowest monocyte percentage compared to the control group.  
Despite this observation, the differences were not statistically significant. 
 
Figure 4.6 (d): Median values for the neutrophil percentage of all the groups 
* = Statistically significant difference (p<0.05) 
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Figure 4.6d indicates that the neutrophil percentage for group A was statistically 
significantly lower than that of the control group.  The percentages of group B and 
C were also lower than that of the control group, but the differences were not 
statistically significant. 
 
Figure 4.6 (e): Median values for the eosinophil percentage of all the groups 
Although the eosinophil percentage for group A was 50% lower than the 
percentages for groups B, C and the control group, the differences were not 
statistically significant (Figure 4.6e). 
 
Figure 4.6 (f): Median values for the basophil percentage of all the groups 
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From Figure 4.6f it is evident that there were no statistically significant differences 
in basophil percentages between any of the exposure groups and between the 
exposure groups and the control group. 
4.3.1.3.1 Summary of comparative mean / median values for the leukocyte 
parameters 
The data revealed a statistically significant mean or median difference in total 
leukocyte (p=0.0391), lymphocyte (p=0.0149) and neutrophil (p=0.0014) values 
between group A (24-hour exposure) and the control group.  For the monocytes, 
eosinophils and basophils, there were no statistically significant median 
differences between the experimental groups and the control group (p>0.05). 
There was an increased mean total leukocyte count and the median lymphocyte 
count for the mice in the 24-hour exposure group (group A).  Figure 4.6 (b) 
illustrates that the lymphocyte counts increased exponentially, with the lowest 
count found in group C and the highest count in group A.  Although group B and 
group C indicated no statistically significant difference from the control group, it 
was noted that there seemed to be a trend where the lymphocyte values 
increased with increased duration of exposure. 
In contrast to the increased lymphocyte count, the neutrophil count for group A 
was statistically significantly lower (p=0.0014) than that of the control group.  As 
with the analysis of the former group, Figure 4.6 (d) reveals that there was an 
exponential decrease, but that the difference between group B and group C was 
not statistically significant. 
Figures 4.6 (c) and 4.6 (e) reveal that there were lower monocyte (p=0.0833) and 
eosinophil (p=0.1360) values for group A compared to the control group, but 
these were not statistically significant.  For the monocytes, there was an apparent 
trend to decrease with increased exposure time.  In spite of the differences not 
being statistically significant, the monocytes showed a clear exponential increase 
from group A (24-hour group) to group C (1-hour group). 
It was observed that the statistically significant difference between the exposure 
groups and the control group seemed to increase as the duration of exposure 
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increased.  Moreover, in spite of the differences not all being statistically 
significant, many parameters became statistically significant in group A (24-hour 
exposure), which was the maximum exposure duration. 
Table 4.6 depicts the differences for leukocyte parameters between all the groups 
using the ANOVA and Kruskal-Wallis test and between the individual groups 
(intergroup comparison) using the t-test or Kruskal-Wallis test.  Keep in mind that 
the Kruskal Wallis test was used for data with median values. 
Table 4.6: Intergroup comparison for leukocyte parameters 
Parameter 
A vs. B vs. C 
(ANOVA/ Kruskal-
Wallis Test) 
p-value 
A vs. B (t-test/ 
Kruskal-Wallis 
Test) 
p-value 
A vs. C (t-test/ 
Kruskal-Wallis 
Test) 
p-value 
B vs. C (t-test/ 
Kruskal-Wallis 
Test) 
p-value 
Total 
Leukocytes 
0.3772 0.6520 0.1830 0.3385 
Lymphocytes 0.0338 0.0423 0.0151 0.7195 
Monocytes 0.1563 0.1272 0.0771 0.7709 
Neutrophils 0.0190 0.0435 0.0072 0.4786 
Eosinophils 0.2636 0.2379 0.1219 0.6228 
Basophils 0.1475 0.7251 0.0945 0.0879 
(p<0.05 indicates statistically significant difference) 
The histograms in Figures 4.7 (a-f) depict the data for the intergroup comparison 
in Table 4.6. 
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Figure 4.7 (a): Intergroup comparison of mean total leukocyte counts 
Figure 4.7a shows that no statistically significant differences were found for the 
intergroup comparison between the exposure groups for the total leukocyte 
counts.  The largest difference was observed between group A and group C. 
 
Figure 4.7 (b): Intergroup comparison of median lymphocyte percentages 
* = Statistically significant difference (p<0.05) 
From Figure 4.7b it is evident that there was a statistically significant difference 
between groups A and B as well as between groups A and C when conducting 
the intergroup comparison.  The result of the intergroup comparison between 
groups B and C showed no statistically significant difference. 
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Figure 4.7 (c): Intergroup comparison of median monocyte percentages 
The intergroup comparisons for the monocyte counts were not statistically 
significant for any of the groups as seen in Figure 4.7c.  However, despite the fact 
that it was not statistically significant, a difference was noted between groups A 
and B as well as between groups B and C. 
 
Figure 4.7 (d): Intergroup comparison of median neutrophil percentages 
* = Statistically significant difference (p<0.05) 
Figure 4.7d reveals that there was a statistically significant difference for the 
intergroup comparison of the neutrophil counts between groups A and B as well 
as between groups A and C.  There was no significant difference between groups 
B and C. 
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Figure 4.7 (e): Intergroup comparison of median eosinophil percentages 
From Figure 4.7e it can be seen that although there were 50 % intergroup 
differences between groups A and B as well as between groups A and C for the 
eosinophil counts, these differences were not statistically significant. 
 
Figure 4.7 (f): Intergroup comparison of median basophil percentages 
The basophils were the last of the leukocyte differential counts.  In Figure 4.7f it is 
clear that there was no intergroup variation between the exposure groups for the 
basophil counts. 
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4.3.1.3.2 Summary of intergroup comparison for mean / median leukocyte 
parameters 
The results presented in Table 4.6 and Figures 4.7 (a-f) indicate no statistically 
significant intergroup variation for the total leukocyte, monocyte, eosinophil and 
basophil (p>0.05) counts.  However, using the ANOVA test there was a 
statistically significant variation between the three groups for the lymphocyte 
(p=0.0338) and neutrophil (p=0.0190) counts. 
The results for lymphocyte counts indicated a statistically significant median 
difference between groups A and B (p=0.0423) as well as groups A and C 
(p=0.0151), but none was found between groups B and C (p>0.05).  For the 
neutrophils there was a statistically significant median difference between groups 
A and B (p=0.0435) as well as between groups A and C (p=0.0072).  However, 
as with the lymphocytes, no significant difference was found between groups B 
and C (p>0.05).  For both the parameters the most statistically significant median 
differences were found between group A and group C.  From these results it is 
evident that longer exposure duration had an effect on the results. 
4.3.1.3.3 Discussion of findings for leukocyte parameters 
From the results as reported above it was evident that exposure to the ELF-EMF 
signal influenced various leukocyte counts.  There were statistically significant 
differences in the lymphocyte and the neutrophil counts when comparing group A 
to the control group.  The total leukocyte count for group A which was statistically 
significantly higher than that of the control group was most likely due to the 
increased lymphocyte count.  The lymphocyte count was increased, whereas the 
neutrophil count was decreased.  There was also an apparent variation between 
the groups where the inclination increased with the duration of exposure.  The 
biggest difference was found in group A, which was the experimental group that 
received the maximum daily exposure (24-hour exposure).  Hence, the longer the 
exposure, the more statistically significant the differences were.  This confirmed 
the hypothesis that the duration of exposure plays an important role or has a 
significant effect on the immune cell counts.  This effect due to duration of 
exposure was also reported by Goraca et al. (2010).  These authors explained 
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that the oxidative stress parameters achieved in their study depended on the 
“working time” (i.e., duration of exposure) of the ELF-EMF. 
The increased leukocyte count in the current study could possibly indicate an 
immune stimulation.  In the human body, immune stimulation is characterized by 
an increased lymphocyte count since the lymphocytes become activated when 
stimulated by a “foreign agent or stimulus” (Coico & Sunshine, 2009:2).  Markov 
et al., (2006) found that ELF-EMFs do indeed interact with lymphocytes.  
Selmaoui et al., (2011) found an increased IL-6 in healthy young men exposed to 
a 9h intermittent field (10 µT).  An increased leukocyte count can, therefore, 
possibly be due to increased cytokine production (Aldinucci & Pessina, 1998; 
Cuppen et al., 2006; Selmaoui et al., 2011).  This could possibly also explain the 
association with the increased lymphocyte concentration in this study.  The 
reason for this is that activation of the innate immune system is accompanied by 
cytokine production (de Kleijn et al., 2011).  These cytokines play an important 
role in T-lymphocyte differentiation in the immune response.  In Table 2.1 it is 
indicated that IL-6 is responsible for activation of T-cells. 
These findings are contradictory to the findings of Hashish et al. (2008).  In their 
study they found a decrease in leukocyte and platelet numbers and an increase 
in granulocyte numbers.  However, the exposure period was longer than in this 
study and the signal strength differed from the Immunent signal in the current 
study. 
Markov (2006) found that ELF-EMFs affected homeostatically unstable cells.  
From this finding, one can possibly deduce that the immune system becomes 
homeostatically unstable when exposed to these EMFs.  This will concur with the 
hypothesis of Cuppen et al. (2006) that ELF-EMFs can “put the immune system 
into a state of alert”. 
The decreased neutrophil count in the current study does not support this 
statement, but the findings by Elmusharaf et al. (2007) could provide a possible 
explanation for the decreased neutrophil count.  In their study conducted on 
broiler chickens with intestinal coccidiosis lesions caused by the Eimeria species, 
it was found that there was a reduction in intestinal lesions after exposure to ELF-
 86 
 
EMFs (Elmusharaf et al., 2007).  This finding suggested an antagonistic effect on 
coccidiosis by the ELF-EMFs.  The authors suggest that this could possibly be 
due to an increased blood flow, similar to an inflammatory reaction, as well as the 
relocalization or colonization of phagocytic cells to damaged tissues.  This then 
resulted in an increased phagocyte infiltration to damaged tissues to aid in the 
response to the pathogen.  The researcher is of the opinion that this suggestion 
by Elmusharaf et al., (2007) could possibly explain the reduced neutrophil count 
in the current study.  In other words, the neutrophil count was decreased in the 
peripheral blood due to relocation of these cells to the other tissues in the body 
when being stimulated by the applied ELF-EMF.  
de Kleijn et al., (2011) mention that inflammatory cytokines play a role in 
regulation of other immune cells such as neutrophils.  Coico, Sunshine and 
Benjamini (2003:151) explain that neutrophil migration (also known as 
transendothelial migration) occurs under the influence of cytokines. This 
migration is illustrated in Figure 4.8.  One of the cytokines involved in this process 
is IL-8. 
 
http://www.bio.davidson.edu/courses/immunology/students/spring2006/, accessed 18 September 2012 
Figure 4.8: The process of transendothelial migration by neutrophils 
 87 
 
The finding of increased phagocytic activity following short-term exposure to ELF-
EMFs has been described by several authors (Rollwitz et al., 2004; Simko & 
Mattson, 2004; Hashish et al., 2008; Goraca et al., 2010; de Kleijn et al., 2011). 
Increased granulocyte activity is associated with increased superoxide anion (O2 / 
free radical) production (Khadir et al., 1999).  Consider the findings of Varani et 
al., (2002) as presented in section 2.2.5.2, who found that ELF-EMF exposure 
resulted in an increase of A2A adenosine receptor density.  They mention that 
adenosine receptors interact on the neutrophil surface as an anti-inflammatory 
agent.  Once again, we have another possible biological mechanism to consider 
in explaining the involvement of neutrophils in the immune response following 
exposure to ELF-EMFs. 
A great deal of literature has been published indicating the effect that ELF-EMF 
exposure has on the release of biologically active substances such as stress 
proteins (Goodman & Blank, 1998; Blank & Goodman, 2000; Blank & Goodman, 
2009) and the production of free radicals (Simko et al., 2001; Rollwitz et al., 2004; 
Simko & Mattsson, 2004; Hashish et al., 2008; Goraca et al., 2010; Cifra et al., 
2011; de Kleijn et al., 2011; Mattsson & Simko, 2012).  Reactive oxygen species 
(ROS) are produced by phagocytes once they have been stimulated.  Hence, 
ROS production seems to be a key process in the stimulatory effect of ELF-EMFs.  
Once again, as indicated by de Bruyn and de Jager (1994), this process results in 
stress when exposed long term.  The findings of Hashish et al. (2008) concur with 
this.  In their study they found that mice exposed to a 50 Hz (1.4 mT) ELF-EMF 
for thirty days had a decreased total leukocyte, platelet, monocyte, peripheral 
lymphocyte, splenic lymphocyte, T-cell and B-cell counts.  This finding is 
contradictory to the findings of the current study, but it must be kept in mind that 
in their study the exposure duration was longer and the field strength was 
stronger (1.4 mT). 
Hence, short-term exposure to ELF-EMFs seems to be a key factor to achieving 
the effects of immune stimulation.  The increased lymphocytes provide evidence 
of immune stimulation.  In addition the theory of transendothelial migration also 
provides evidence of immune stimulation. 
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4.3.2 Immunophenotyping 
The descriptive statistics and statistical significance for mean differences 
between the experimental groups and the control group for the 
immunophenotyping parameters are summarized in Table 4.7.  The 
immunophenotyping parameters and their units of measurement included the 
following: 
 CD3 (Total T-lymphocytes), expressed as a percentage of the total 
lymphocyte count. 
 CD4 (Suppressor T-Lymphocytes), expressed as a percentage of the total 
lymphocyte count. 
 CD8 (Cytotoxic T-lymphocytes), expressed as a percentage of the total 
lymphocyte count. 
 CD19 (B-lymphocytes), expressed as a percentage of the total lymphocyte 
count. 
Table 4.7: Descriptive statistics and p-values for mean 
immunophenotyping parameters 
Parameter  A B C K 
CD3 
Mean (%) 34.13 34.17 35.77 25.70 
SD 8.86 11.64 11.01 13.73 
p-value t-test 0.0218 0.0372 0.0137  
CD4 
Mean (%) 26.52 25.72 26.87 19.20 
SD 7.01 8.65 8.81 11.11 
p-value t-test 0.0138 0.0400 0.0193  
CD8 
Mean (%) 8.37 8.43 9.94 6.7 
SD 2.96 3.35 2.85 3.19 
p-value t-test 0.0762 0.0934 0.0015  
CD19 
Mean (%) 23.08 23.22 17.32 17.88 
SD 12.10 12.03 12.78 13.77 
p-value t-test 0.1849 0.1885 0.8933  
(p<0.05 indicates statistically significant difference) 
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Figures 4.9 (a - d) present a graphic view and representation of the data in Table 
4.7.  Separate histograms were created for each specific parameter, even though 
the units of measurement were the same.  This was to simplify visualization of the 
exposure group results compared to those of the control group. 
 
Figure 4.9 (a): Mean values for CD3 percentages of all the groups 
* = Statistically significant difference (p<0.05) 
The CD3 percentages for all three exposure groups were statistically significantly 
higher than the percentage for the control group as can be seen in Figure 4.9a.  
There was a slight increase in values as the exposure duration decreased. 
 
Figure 4.9 (b): Mean values for CD4 percentages of all the groups 
* = Statistically significant difference (p<0.05) 
* * * 
0
5
10
15
20
25
30
35
40
GroupA GroupB GroupC GroupK
CD3 (%) 
GroupA
GroupB
GroupC
GroupK
* * * 
0
5
10
15
20
25
30
35
40
GroupA GroupB GroupC GroupK
CD4 (%) 
GroupA
GroupB
GroupC
GroupK
 90 
 
In Figure 4.9b it was found, once again, the CD4 percentages of all three the 
exposure groups were found to be statistically significantly higher than the the 
percentage for the control group.  In this case there was no trend regarding the 
duration of exposure. 
 
Figure 4.9 (c): Mean values for CD8 percentages of all the groups 
* = Statistically significant difference (p<0.05) 
For the CD8 analysis, Figure 4.9c shows that only group C was found to be 
statistically significantly higher than the control group.  The differences for groups 
A and B were not statistically significant. 
 
Figure 4.9 (d): Mean values for CD19 percentages of all the groups 
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Upon determination of the CD19 markers, there were no statistically significant 
differences between the exposure groups and the control group.  Figure 4.9d 
shows that group A and group B seemed to be somewhat higher than the control, 
in spite of the lack of statistical significance. 
Figure 4.10 represents a collective summary of histograms for all the CD markers.  
This summary includes the total T-lymphocyte (CD3), T-helper lymphocyte (CD4), 
cytotoxic T-lymphocyte (CD8) and the B-lymphocyte markers. 
 
Figure 4.10: Combined histogram of all immunophenotyping parameters showing a 
comparison between the exposure and the control groups 
* = Statistically significant difference (p<0.05) 
4.3.2.1 Summary of comparative mean values for the immunophenotyping parameters 
There was a statistically significant mean difference in the CD3 counts between 
groups A (p=0.0218), B (p=0.0372), C (0.0137) and the control group.  In addition, 
a statistically significant mean difference in CD4 counts was found between 
groups A (p=0.0138), B (p=0.0400), C (p=0.0193) and the control group was 
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found.  For the CD8 counts, only group C showed a statistically significant mean 
difference (p=0.0015) compared to that of the control group.  No statistically 
significant mean differences were found between any of the exposure groups and 
the control group for CD19 counts. 
Table 4.8, below, indicates the differences between all of the groups using the 
ANOVA test and between the individual groups (intergroup comparison). 
Table 4.8: Intergroup comparison for immunophenotyping parameters 
Parameter 
A vs. B vs. C 
(ANOVA) 
p-value 
A vs. B (t-test) 
p-value 
A vs. C (t-test) 
p-value 
B vs. C (t-test) 
p-value 
CD3 0.8480 0.9892 0.5869 0.6545 
CD4 0.8974 0.7330 0.8859 0.6767 
CD8 0.1800 0.9438 0.0815 0.1295 
CD19 0.2194 0.9683 0.1331 0.1360 
(p<0.05 indicates statistically significant difference) 
The graphic representations of the intergroup comparisons are presented in 
Figures 4.11 (a - d). 
 
Figure 4.11 (a): Intergroup comparison of mean CD3 percentages 
From the histogram in Figure 4.11a it is clear that there were no statistically 
significant differences for the intergroup comparisons.  It did appear as though 
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the value for group C was higher than the values for groups A and B, but the 
differences were not statistically significant. 
 
Figure 4.11 (b): Intergroup comparison of mean CD4 percentages 
It is apparent in Figure 4.11b that there were no intergroup variations for the CD4 
analysis.  This was also evident due to the lack of statistical significance.  There 
was a slight variation between groups A and B as well as between groups B and 
C. 
 
Figure 4.11 (c): Intergroup comparison of mean CD8 percentages 
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There was no evidence of intergroup variation for the CD8 analysis.  As seen in 
Figure 4.11c the value for group C seemed to be slightly higher than the values 
for groups A and B, but the differences lacked statistical significance. 
 
Figure 4.11 (d): Intergroup comparison of mean CD19 percentages 
When looking at Figure 4.11d, it seemed as though there was a significant 
intergroup variation between groups A and C as well as between groups B and C 
for the CD 19 analysis.  However, these variations were not statistically significant. 
4.3.2.2 Summary of intergroup comparison for mean immunophenotyping parameters 
There were no statistically significant differences (p>0.05) between any of the 
exposure groups themselves (24-hour, 4-hour and 1-hour exposure) for the 
immunophenotyping parameters.  The ANOVA test (A vs. B vs. C) indicated no 
statistically significant differences (p>0.05) between the exposure groups for the 
immunophenotyping parameters.  Thus, the duration of exposure did not seem to 
have any effect on the immunophenotyping results. 
4.3.2.3 Discussion of findings for immunophenotyping parameters 
Taking a critical view at the results obtained for the immunophenotyping, it was 
found that short-term exposure to the selected ELF-EMF resulted in increased 
CD3 and CD4 lymphocyte counts for all the exposure groups (24-hour, 4-hour 
and 1-hour exposure).  The most significant increase in values was seen in group 
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C (one hour exposure).  There was also a significant increase in CD8 counts for 
group C.  There were no statistically significant differences for CD19 counts. 
It merits mentioning that the increased total leukocyte counts for the leukocyte 
parameters were probably due to the increased lymphocyte counts.  It can be 
concluded that T-lymphocytes (CD3) represented the specific group of 
lymphocytes that were increased. 
Therefore, short-term exposure of the specific Immunent signal resulted in 
increased T-cell counts, but had no effect on B-cell counts.  Since there were no 
statistically significant differences found in the intergroup comparison, it can be 
deduced that the duration of exposure did not affect the results of the 
immunophenotyping. 
A possible explanation for the increased CD3+ and CD4+ lymphocyte counts for 
all the exposure groups (24-hour, 4-hour and 1-hour exposure) could be that the 
T-lymphocytes were signalled by the increased IL-6 levels.  This confirms the 
findings of Selmaoui et al. (2011), who reported raised IL-6 levels in young men 
when exposed to 50 Hz EMFs.  The increase, and possible activation, of CD4+ 
cells can then result in activation and hence an increased number of CD8+ cells 
(Coico, Sunshine and Benjamini, 2003:139). 
In evaluating the findings, it seems important to keep the findings of Aldinucci & 
Pessina (1998) in mind, as they found an increased INFγ and IL-6 with 50 Hz 
exposure.  It is known that IL-6 activates T-cells and IL-2 production (Coico, 
Sunshine and Benjamini, 2003:153).  CD4 cells also produce IL-2 which, in turn, 
induces proliferation and differentiation of CD8+ cells (Coico, Sunshine and 
Benjamini, 2003:139).  This could possibly be the underlying biological process 
resulting in the increased CD4 counts and also the increased CD8 count in group 
C.  These results agree well with the results of the leukocyte parameters reported 
in section 4.3.1.3.  Hence, it was clear that the lymphocyte counts were limited to 
the T-lymphocytes. 
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4.4 Summary of discussion 
4.4.1 Literature summary 
Wertheimer and Leeper (1979) found the strongest evidence of adverse effects 
resulting from exposure to EMFs.  They found that there was a substantial 
increased risk of childhood cancer in families living close to power lines.  In this 
case their argument carries a great deal of weight, but the EMFs they 
investigated do not correspond with the fields investigated in this study. 
Research in this field later indicated toward evidence of adverse health effects 
due to long-term exposure to ELF-EMFs (Ahlbom & Feychting, 2003; de Bruyn & 
de Jager, 1994; Mevissen et al., 1998).  Goraca et al. (2010) also found that the 
effect was dose-dependent.  Johansson (2009) felt that the effect of chronic 
exposure to EMFs is underestimated.  This author suggested increased safety 
limits for public exposure. 
Gobba et al. (2009) reported that occupational exposure of subjects to higher 
field strength ELF-EMFs had lower NK cell counts than subjects exposed to the 
lower field strengths (less than 2 µT).  Limited publications could be found that 
reported on leukocyte counts or counts of other immune cells to support these 
findings. 
In spite of the concern for the possibility of adverse health effects, research has 
also indicated that exposure to ELF-EMFs can be beneficial to human health and 
that they have therefore been used therapeutically for various conditions 
(Vallbona & Richards, 1999; Markov et al., 2006; Waite et al., 2011).  However, 
most of these findings lacked evidence of the biological mechanism. 
One very common feature emanating from a large number of scientific 
investigations with regard to biological mechanism is the fact that ELF-EMFs 
increase ROS production (Simko et al., 2001; Rollwitz et al., 2004; Simko & 
Mattson, 2004; Hashish et al., 2008; Goraca et al., 2010; Mattsson & Simko, 
2012).  This provides strong evidence that the innate immune system is triggered. 
 97 
 
Then there were also the findings of increased cytokine production which may 
indicate towards stimulation of the immune response (Aldinucci & Pessina, 1998; 
Selmaoui et al., 2011; de Kleijn et.al., 2011).  However, it is evident that any 
beneficial effects are limited to short-term exposure to ELF-EMFs.  Several 
investigations have shown that there is an interaction between EMFs and 
immune cells, but there still seems to be some basic information lacking in this 
field (Markov et al., 2006).  There is a possibility that the link to this understanding 
perhaps lies in the specificity of the signal and the dosimetry. 
Since it has been strongly suggested that exposure to ELF-EMFs results in 
increased ROS production, thereby eliciting an anti-inflammatory response, it is 
evident that this effect takes place at cellular level.  Markov et al. (2006) 
concentrated on the effects of these fields at immune cell level.  They 
hypothesized that beneficial health effects, specifically on the immune system, 
could be obtained by regulation of the inflammatory response.  Based on their 
findings, they argued strongly that further research should concentrate on fields 
with specific physical characteristics. 
A factor to consider in the therapeutic application of EMFs is that the physics and 
engineering of EMF signals are specific (Markov & Hazlewood, 2009).  A specific 
signal might be beneficial for application in one biological area, but not in another.  
With regard to this specificity, the Immunent Activator signal seems most 
appropriate, since this signal is specific and unique. 
Supportive research on the benefits obtained by exposure to the Immunent 
Activator signal may have significant financial implications.  Benefits in the 
farming industry have been suggested (Cuppen et al., 2007).  A platform of 
intense investigation with a wide field of research opportunities has therefore 
been created.  However, it has become apparent that this is an area of research 
which, to a great extent, needs supportive research.  In this regard the Immunent 
Activator signal was tested by, among others, Waite et al., (2011), who suggested 
the possibility of therapeutic use due to its specific characteristics. 
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4.4.2 Summary of findings from the present study 
The most significant statistical differences were found in the leukocyte 
parameters, and such differences were also evident in and confirmed by the 
immunophenotyping results.  For the full blood count this significant difference 
was not observed in all of the exposure groups, but for CD3 and CD4 counts a 
statistically significant difference was evident in all of the exposure groups.  For 
the intergroup analysis there was a statistically significant difference between 
some of the exposure groups.  Most of the results indicated toward group A as 
the group with the most common and most statistically significant differences. 
For the leukocyte parameters, the lymphocyte counts in group A were increased 
and the neutrophil counts were decreased.  In spite of the lower neutrophil counts, 
the total leukocyte count in group A was still higher than the count of the control 
group. 
The lower neutrophil counts could be associated with transendothelial migration.  
If this were to be true, the findings of many authors indicating increased ROS 
production will corroborate this biological process. 
From the immunophenotyping results it is evident that short-term exposure to the 
Immunent Activator signal resulted in stimulation of specifically the T-lymphocytes.  
This could be deduced from the fact that a significant increase was observed in 
the CD3 (total T-lymphocyte population), CD4 (helper T-lymphocytes) and CD8 
(cytotoxic T-lymphocytes).  No statistically significant differences were found for 
the CD19 (B-lymphocyte population). 
Cuppen et al. (2007) hypothesized that the immune system is put into a “state of 
alert” when exposed to ELF-EMFs.  This is as a result of stress induction on the 
cells.  There was evidence from this study that the T-lymphocytes and the 
neutrophils were activated.  This was possibly due to stress induction on the cells 
by the EMF. 
A prominent observation in the current study was the increased leukocyte count.  
This was most likely due to the increased lymphocyte count, which related 
specifically to T-lymphocytes (CD3). 
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From the current study, there is strong evidence of immune stimulation.  This was 
evident from the total leukocyte count that was statistically significantly higher in 
the exposed groups compared to the unexposed group.  Nihal et al. (2012) found 
similar results in their study. 
Upon investigation of the specificity of the increased leukocytes it was apparent 
that this increased value was specific for the lymphocytes.  This finding was 
largely limited to the 24-hour exposure group.  It was also evident that the 
duration of exposure had an effect on the lymphocyte count.  The significance 
indicated a tendency to increase as the duration of exposure increased.  An 
increase in lymphocyte count signifies immune stimulation.  A mechanism of 
action to be proposed is one of increased T-lymphocyte count due to stimulation 
by increased interleukin production. 
The immunophenotyping results showed that the increased lymphocyte count 
was specific for T-lymphocytes, since there was a statistically significant increase 
in CD3 and CD4 cells for all the exposure groups, with the highest significance 
levels in the 24-hour and the 1-hour exposure groups.  However, for CD8 cells 
this was only observed in the one hour exposure groups.  
The decreased neutrophil count for the 24-hour exposure group was the 
parameter which was found most challenging to explain.  In view of the 
hypothesis suggested by Elmusharaf et al. (2007), the low neutrophil count could 
possibly indicate toward relocalization or colonization of phagocytic cells to the 
tissues.  If the finding of increased ROS production holds true, the neutrophil 
counts from this study would support the theory of Elmusharaf et al. (2007).  The 
possible increased production of interleukins could account for increased ROS 
production and relocation of phagocytic cells. 
Since research has indicated that long-term exposure to ELF-EMFs results in 
oxidative stress due to prolonged ROS production, the researcher is of the 
opinion that short-term exposure could alert the immune system and be used 
therapeutically as was hypothesized by Simko & Mattsson (2004).  It is, therefore, 
possible that the Immunent Activator signal can be used to therapeutically 
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manipulate the immune response by serving as an antigenic signal.  This 
conclusion is based on the evidence of increased T-lymphocytes. 
EMF exposure tends to elicit an inflammatory response (Johansson, 2009; 
Mattson & Simko, 2012).  If this inflammatory response is elicited for only a short 
period of time, it could very well put the immune system into a state of alert.  The 
inflammatory response is beneficial if there is an appropriate feedback 
mechanism and the response is limited to a short period.  If the inflammatory 
response continues for an extended period there is a possibility of tissue damage.  
This has been indicated by de Bruyn and de Jager (1994).  This study strongly 
agrees with the suggestions made by Markov et al. (2006) that EMF therapy can 
be used for treatment of inflammatory diseases and pain, since T-lymphocytes 
are one of the key modulators of inflammation.  Hence, these EMFs can, in effect, 
be used as regulators of the inflammatory process. 
Selmaoui et al. (2011) found an increased IL-6 in healthy young men exposed to 
a nine hour intermittent field (10 µT).  This could possibly also explain the 
association with the increased lymphocyte concentration in this study.  The 
reason for this is that activation of the innate immune system is accompanied by 
cytokine production (de Kleijn et al., 2011).  These cytokines play an important 
role in T-lymphocyte differentiation in the immune response.  Considering that IL-
6 is secreted by T-cells and is also responsible for the activation of T-cells and IL-
2 production, it would fit in with the findings of increased lymphocyte (specifically 
T-cells) counts in the current study and the findings by Selmaoui et al., (2011) of 
increased IL-6.  These findings are supported by those of Aldinucci & Pessina 
(1998), whose study revealed enhanced release of IL-6 and INFγ after exposure 
to 50 Hz ELF-EMF, which resulted in improved biological responses.  INFγ is also 
secreted by TH1 cells and is responsible for activation of NK cells and 
macrophages as well as the inhibition of TH2 cells (Coico, Sunshine and 
Benjamini, 2003:154). 
The cells which indicated the most obvious interaction with ELF-EMFs in the 
current study were the T-lymphocytes and neutrophils.  These leukocytes are key 
regulators of the immune response.  The researcher suggests that T-lymphocytes 
proliferate in response to ELF-EMF exposure in an attempt to launch an immune 
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response to a “stimulus”.  In this case the immune response is alerted in 
response to a pathogen introduced to the body.  Evidently this also has a 
beneficial effect on the healing process of the body.  As far as the neutrophils 
were concerned, the researcher believes this finding coincides well with the 
finding by Elmusharaf et al. (2007), where the neutrophils migrated to the tissue 
in response to EMF exposure, hence resulting in decreased peripheral blood 
counts. 
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CHAPTER 5 
CONCLUSIONS AND REFLECTIONS 
5.1 Introduction 
Despite constant concern regarding the effects that daily exposure to ELF-EMFs 
has on human health, there is limited evidence that these EMFs can adversely 
affect human health.  These “technofields” as described by Havas (2000), 
surround us daily and in some instances, all day.  One can argue that the human 
race has adapted to this exposure as technology has advanced throughout the 
centuries, but the argument would hold no weight in the absence of supportive 
scientific evidence.  In spite of extensive investigations conducted by the National 
Institute of Environmental Health Sciences and the Department of Energy in this 
field, conclusive evidence that exposure to these fields poses a health risk 
remains absent or, at best, nebulous.  Yet there is equally insufficient evidence to 
show that exposure to these fields could be considered safe or beneficial.  This 
study did, however, indicate that short-term exposure to the Immunent Activator 
signal which creates ELF-EMFs can stimulate the immune response.  These 
findings can be helpful in identifying a possible therapeutic application for ELF-
EMFs. 
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5.2 Conclusions 
The following are the most significant conclusions of the study: 
 The comparative data revealed that there was a significant difference in 
lymphocyte and neutrophil counts between the exposure groups and the 
control group, hence indicating that short-term exposure to the Immunent 
Activator signal did in fact stimulate an immune response.  
 Intergroup comparisons revealed that there was a statistically significant 
variation between the different groups for the lymphocyte and neutrophil 
counts, hence confirming that the duration of exposure had an effect on 
the cell counts. 
 The immunophenotyping analysis for specific lymphocyte sub-populations 
revealed that only T-lymphocytes presented any significant differences.  
These included the CD3, CD4 and CD8 lymphocyte populations.  No 
statistically significant difference was found for the B-lymphocytes (CD19). 
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5.3 Limitations of the study 
Several challenges were faced during the course of the study which included the 
following: 
 Since research has indicated a correlation between short-term 
exposure to ELF-EMFs and an increased ROS production in 
phagocytes such as neutrophils and macrophages, it would have been 
ideal to include the oxidative burst test which determines ROS 
production.  This investigation was not included in the present study for 
the following reasons: 
o Failure to validate a method before initializing the study. 
o The volume of blood obtained from mice is limited and it would 
have been impossible to do all the biological analyses on the 
small amount of blood collected. 
o Financial constraints. 
 In some instances the blood tended to clot during the bleeding 
procedure, therefore clotted samples could not be included in the 
biological analyses. 
 Initially, it was intended to include CD56 (natural killer cells) counts in 
the immunophenotyping.  This marker is costly and financial constraints 
made it impossible to include this marker for analysis. 
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5.4 Recommendation for future investigations 
This study provided supporting evidence that confirmatory studies should be 
performed on the Immunent Activator signal.  There was a strong indication that 
interleukins played one of the key roles in the findings from this study.  Hence, 
the following future investigations are advised: 
 Further studies on interleukin production are required to investigate the 
mechanism behind the increased T-lymphocyte counts.  The specific 
interleukins for investigation should be IL-2, IL-6 and INFγ.  Investigation 
on pro-inflammatory cytokines is also advised.  These would include IL-8 
and IL-16. 
 Future investigations on IL-8 to investigate the suggestion of neutrophil 
migration should be conducted, since this cytokine stimulates the migration 
of phagocytes. 
 A successive study to confirm the ROS production of phagocytes using the 
Immunent Activator signal is recommended. 
 It is recommended that the investigation be repeated to compare results of 
healthy mice with disease-challenged mice.  Hence, a follow-up study is 
advised where mice are challenged with a “disease” or “organism”.  Such a 
study would coincide with a recommendation by Markov et al. (2006) who 
suggested further studies on cells which are “out of equilibrium”.  To 
determine the effect of the Immunent Activator signal on challenged 
animals could corroborate the findings of this study and other studies 
related to this one. 
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5.5 Concluding comments 
Numerous studies have been performed to investigate possible health effects of 
ELF-EMF exposure.  It has become clear that long-term exposure to these fields 
has detrimental health effects, whereas short-term exposure could hold beneficial 
health effects.  However, many of the studies were not clear on the biological 
mechanism of action and a few hypotheses have been offered suggesting an 
inflammatory response due to cytokine release.  A review of findings reported in 
the literature repeatedly indicated towards the involvement of cytokines.  When 
integrating the results from this study with those reported in the literature, there is 
a substantiation of cytokine involvement.  Hence, the role of cytokines as a 
mediator for immune stimulation is strongly suggested. 
The researcher is of the opinion that the critical issues in this study were 
dosimetry and the physical characteristics of the ELF-EMF signal.  It is for these 
reasons that it is agreed that future investigations should be from a mechanistic 
point of view.  Hence the Immunent Activator exposure system for further 
investigations is advised. 
The findings of the study lead to the conclusion that short-term (one week) 
exposure to the Immunent Activator signal can stimulate the immune response.  
Hence, the effects and potential therapeutic application of this signal could be 
beneficial to human health. 
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Group Weight 
(g) 
WBC 
(103/mm3) 
RBC 
(106/mm3) 
HGB 
(g/dl) 
HCT (%) MCV 
(µm3) 
PLT 
(103/mm3) 
Lymph 
(%) 
Mono 
(%) 
Neutr 
(%) 
Eosin 
(%) 
Baso 
(%) 
CD3 (%) CD4 (%) CD8 (%) CD19 
(%) 
A1 
26.1 4.3 9.2 14.6 43 47 854 91.3 1.7 6.9 0 0.1 33.1 26.4 10.6 17.2 
A2 
29 6.3 9.4 15.1 44.3 47 784 91.6 1.9 6 0.1 0.4 17.1 13.5 1.7 1.1 
A3 
29.9 7.2 9.3 15.2 44.6 48 16.4 93.1 0.8 5.6 0.1 0.4 27.1 21.3 3.6 6.5 
A4 
25 5.9 9.7 15.5 46.5 48 822 92,2 1.4 6.1 0 0.3 40.1 29.5 13.9 16.3 
A5 
31.2 8.7 9.6 14.8 45 47 932 93.4 1.7 4.6 0 0.3 55.5 44.8 13.9 30.1 
A6 
32.3 6 9.8 15.5 46.5 47 847 92 1.4 6.3 0 0.3 39.9 29.6 8.7 14.5 
A7 
29.7 7.6 9.9 15.9 46.9 48 861 94.4 1.1 3.8 0.1 0.6 33.3 25.7 9.4 35.7 
A8 
32.6 7.2 8.9 13.9 41.8 47 974 94.1 1.4 3.7 0.3 0.5 28.4 22.5 9.1 15 
A9 
37.3 6.9 9 14.1 43.7 48 829 90.5 2.8 6.1 0.1 0.5 36.7 29.5 10.2 9.6 
A10 
27 5.9 9.5 15.2 45.5 48 960 88.2 2.6 8.7 0.1 0.4 30.3 23.7 7.1 29.2 
A11 
30.1 7 9.2 14.6 43.8 48 776 88.3 2.6 8.7 0.1 0.3 32.3 25.1 9.9 10.4 
A12 
23.9 8.3 9 14.2 42.4 47 871 86.7 3.1 9.4 0.5 0.3 40.3 31.4 10.3 33.7 
A13 
24.9 6.8 9.6 15.5 45.7 48 785 84.4 3.2 11 1 0.4 27.8 20.2 5.8 17.3 
A14 
26.8 3.8 9.2 14.4 43.1 47 844 87.9 2.3 8.5 0.7 0.6 30 23.7 6 21 
A15 
28.2 6.6 9.6 15 45.5 48 781 86.4 3.6 9.2 0.3 0.5 33.5 26 8.2 39.9 
A16 
30.8 8.6 8.9 14.4 42.5 48 1023 94.6 1.6 2.7 0.2 0.9 43.2 34 9.6 43.8 
A17 
26.7 11.6 9.4 14.6 43.9 47 1004 79.4 13.6 6.5 0 0.5 42.3 32.3 9.6 30.9 
A18 
28.6 8.1 9.4 14.9 44.2 47 457 94.7 1.7 3 0.1 0.5 38 28.6 10.1 12.1 
A19 
29.9 6.6 9.4 15 44.3 47 944 86.8 4.1 8 0.5 0.6 4.8 3.3 1.3 2.7 
A20 
24.3 9.5 9.3 14.4 43.3 47 1006 87.8 4.1 7.4 0.1 0.6 26.6 21 6.7 31.6 
A21 
27.2 8.3 9.2 14.2 43.1 47 725 88.3 2.6 8.7 0.1 0.3 29.8 22.4 7.3 21.1 
A22 
27.3 7.7 9.3 14.4 44.2 48 888 87.9 3.7 7.9 0.1 0.4 34.3 26.6 8.5 37.1 
A23 
25.3 7 9.2 14.4 43.4 47 879 91.8 1.8 6 0.1 0.3 44.9 35.3 10.1 36.4 
A24 
28.3 9.6 8.9 14.3 43 48 854 90.2 3.6 5.5 0.1 0.6 40.2 31.9 7.6 33.9 
A25 
26.6 5.9 9 14.9 42.8 48 853 83.8 3.6 12 0.2 0.4 14.3 11.5 2.9 9.4 
Average 
26.35 5.1 9.1 14.75 42.9 47.5 853.5 87.55 2.65 9.45 0.1 0.25 23.7 18.95 6.75 13.3 
ANNEXURE C: Raw Data Group B 
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Group Weight (g) WBC 
(103/mm3 
RBC 
(106/mm3 
HGB 
(g/dl) 
HCT (%) MCV 
(µm3) 
PLT 
(103/mm3) 
Lymph 
(%) 
Mono 
(%) 
Neutr 
(%) 
Eosin 
(%) 
Baso 
(%) 
CD3 (%) CD4 (%) CD8 (%) CD19 
(%) 
B1 
26.7 9.1 10.2 16.1 48.3 47 773 92.3 2.3 5.1 0 0.3 25.2 19.8 8.5 12.8 
B2 
26.4 9.4 9.5 15 45.1 48 915 91.2 1.3 7.1 0 0.4 49.2 35.4 10.8 30.6 
B3 
25.9 6.9 9.5 15.1 45.2 48 895 91.3 1.4 6.9 0 0.4 43.6 33.7 12.5 15.5 
B4 
26.8 6.9 8.8 14.6 41.8 48 954 82.5 3.2 12.7 1.1 0.5 9.2 6.8 2.9 0.4 
B5 
27.1 5 9.9 15.7 47 48 808 88.3 2.6 8.7 0.1 0.3 16.4 11.7 3 6.5 
B6 
25.1 7.3 8.5 14 40.3 47 442 87.6 3.6 8.2 0.1 0.5 5.4 2.7 2.8 0.7 
B7 
27.9 6.4 8.9 14.5 42 47 1020 85.4 2.2 11.4 0.7 0.3 28.8 20 7.9 32 
B8 
25.6 6.5 9.8 15.4 46.6 48 922 87.1 2 10.1 0.3 0.5 42.1 31 10.4 30.4 
B9 
26.8 4.8 9.4 14.6 44.4 47 661 85.6 3.5 10.1 0.3 0.5 38 28 8.9 9.5 
B10 
26.2 5.3 8.8 13.9 41.4 47 827 85.1 3.5 10.2 0.7 0.5 42.2 31.9 13.4 15.5 
B11 
25.8 7.8 9.3 14.8 44.1 47 991 86.3 2.9 10 0.4 0.4 23.4 19 5.4 15.3 
B12 
28.1 8.2 10 15.5 47.1 47 539 85.7 4.9 8.9 0 0.5 59.6 43.9 15 9.4 
B13 
23.3 6.3 9.1 14.5 43.9 48 1012 87.3 4.4 7.5 0.3 0.5 36 28.4 9.5 26.7 
B14 
27.1 7.4 9 14.5 43.2 48 945 86.6 3.9 8.6 0.4 0.5 34.4 25.3 9.2 28.7 
B15 
28.6 5.3 9.4 14.9 44.4 47 961 84.7 15 0 0 0.3 38 27.9 10.5 30.7 
B16 
25.3 9 9.9 15.5 46.8 47 902 88.8 3 7.7 0.2 0.3 37.3 29.9 7.7 32.1 
B17 
24.7 8.9 8.5 14.1 40.2 47 1119 83.2 4.3 11.5 0.6 0.4 14.2 10.6 2.4 13.2 
B18 
26.9 9.5 9.4 15 44.6 47 930 91.4 1.7 6.3 0.1 0.5 42 32.9 8.9 44.2 
B19 
27.1 7.3 9.9 15.6 46.6 47 428 87.9 2.9 8.7 0.1 0.4 14.8 11.6 2.7 3.2 
B20 
23.1 7.5 9.4 15.2 45.5 48 783 90.9 2.3 6.4 0.1 0.3 34.5 26.4 8.8 29.4 
B21 
24.4 7.6 9.5 14.8 44.5 47 845 92.7 1.4 5.5 0.1 0.3 39.2 29.7 8.6 36.5 
B22 
24.6 7.1 8.9 14.2 41.7 47 817 86 3.8 9.5 0.3 0.4 5.9 4.3 1.3 1.8 
B23 
27.7 6 8.8 14.1 41.5 47 872 88.6 3.5 7.3 0.2 0.4 21.2 15.7 4.6 21.5 
B24 
29.2 4.6 8.1 12.8 37.5 46 688 84.1 4.8 10.2 0.3 0.6 3.4 2.4 1 1.9 
B25 
25.7 6.3 9.1 14.6 43.2 48 879 91.5 2.4 5.3 0.3 0.5 37.4 27.3 8.4 43.9 
Average 
26.2 7.7 9.65 15.35 45.75 47.5 826 91.9 2.35 5.2 0.15 0.4 31.3 23.55 8.45 28.35 
ANNEXURE D: Raw Data Group C 
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Group Weight (g) WBC 
(103/mm3 
RBC 
(106/mm3 
HGB 
(g/dl) 
HCT (%) MCV 
(µm3) 
PLT 
(103/mm3) 
Lymph 
(%) 
Mono 
(%) 
Neutr 
(%) 
Eosin 
(%) 
Baso 
(%) 
CD3 (%) CD4 (%) CD8 (%) CD19 
(%) 
C1 
31.2 6.9 9.7 15.6 46.7 48 659 89.8 2.4 7.4 0.1 0.3 15.2 11.2 7 1.8 
C2 
28 8.1 9.9 15.6 47.2 48 685 87.8 3.8 8 0 0.4 26.8 15.7 5 3.8 
C3 
28.7 5.7 8.8 14.4 41.9 48 924 87.1 2.9 9.6 0.1 0.3 6.8 4.9 1.9 3 
C4 
29 6.9 9.5 15.1 45.4 48 884 91.2 1.7 6.8 0 0.3 50.6 39.4 15.7 3.9 
C5 
30.4 7.1 9.6 14.8 45 47 775 89.2 3.3 7.2 0 0.3 7.9 5.4 4.1 4.9 
C6 
24.3 7.9 9.5 14.8 44.8 47 812 93.2 1.5 5 0 0.3 40.7 31.8 11.7 30.4 
C7 
30 6.6 8.9 13.8 41.8 47 1032 87.3 3.6 8.7 0.1 0.3 36.2 28.1 8.9 16.2 
C8 
26 5.8 8.6 13.6 41.2 48 990 89.1 2.4 7.7 0.4 0.4 39.9 31.2 11.2 20.4 
C9 
29.3 6.3 9.6 15.4 46.2 48 694 85.1 2.5 11.7 0.3 0.4 21.3 15.5 8.6 4.5 
C10 
27.4 4.1 9.5 14.9 44.9 47 947 85.1 2.2 11.9 0.5 0.3 45.7 33.1 13.2 8.7 
C11 
28 4.5 9.1 14.7 43.4 48 818 86.1 1.4 11.9 0.3 0.3 47.7 34.7 14 22.4 
C12 
25.5 5.7 9 14.2 42.9 47 1063 89.7 1.8 8 0.2 0.3 45.7 34.6 12.1 26.3 
C13 
24.6 5.7 9.6 15.5 45.8 48 890 80.1 4.1 14.5 0.8 0.5 35.8 27.7 9.7 7.9 
C14 
24.6 6.3 8.4 13.4 39.6 47 1076 89.2 3.7 6.1 0.5 0.5 38 29.6 10.9 30.7 
C15 
27.2 5.1 7.7 12.4 37.9 49 1049 85.5 7 6.8 0.2 0.5 40.1 30.6 10.5 4.6 
C16 
28.1 7 9.1 14.3 41.7 46 1029 81.6 4.9 12.3 0.8 0.4 3.7 2.9 1 4.4 
C17 
28.1 6.4 9.6 15.5 46.3 48 828 88.3 2.1 9.1 0.2 0.3 50.2 39.2 12.1 23.1 
C18 
21 7.1 8.7 14 41.4 48 654 85.7 4.9 9 0.1 0.3 7 5.3 2.3 2.3 
C19 
24.8 9.3 9.4 14.8 45.1 48 1085 92.7 1.6 5.2 0.1 0.4 37.9 29.6 9.1 45.5 
C20 
23.7 6.9 9.5 15.2 45.1 47 702 86.2 3.1 9.8 0.4 0.5 12.1 8.5 5.8 7.6 
C21 
23.1 10.9 10.1 15.7 48.1 48 500 86.2 4.6 8.1 0.6 0.5 35.3 26.5 8.6 11.4 
C22 
26.7 5.8 9 14.5 42.6 47 910 85 3.9 10.2 0.4 0.5 7.7 6.3 2.1 4.7 
C23 
24.7 7.6 9.3 15 44 47 1254 87.7 4.3 7.2 0.4 0.4 27 19.6 6.4 39.5 
C24 
26.6 6.8 9.3 14.8 44.4 48 1007 86.1 4.4 9.1 0.1 0.3 27 21 7 25.5 
C25 
31.2 6.1 8.9 14.5 43 48 811 85.2 2.5 11.5 0.4 0.4 42.1 29.7 11.3 12.2 
Average 
31.2 6.5 9.3 15.05 44.85 48 735 87.5 2.45 9.45 0.25 0.35 28.65 20.45 9.15 7 
 
ANNEXURE E: Raw Data Control Group 
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Group Weight (g) WBC 
(103/mm3 
RBC 
(106/mm3 
HGB 
(g/dl) 
HCT (%) MCV 
(µm3) 
PLT 
(103/mm3) 
Lymph 
(%) 
Mono 
(%) 
Eosin 
(%) 
Baso 
(%) 
Neutr 
(%) 
CD3 (%) CD4 (%) CD8 (%) CD19 
(%) 
K1 
26.3 6.1 9.5 15.2 45.4 48 775 89.1 3.2 0 0.3 7.4 7.4 5.3 2.7 2.2 
K2 
27.9 3.2 9.2 14.6 43.3 47 858 84.1 5.2 0.2 0.6 9.9 7.4 5.1 2.6 2 
K3 
27.3 5.3 10.3 16.2 48 47 659 86.4 3.5 0.2 0.4 9.5 17.7 12.5 4.8 3.8 
K4 
26.2 6.1 9.2 14.7 43.7 47 809 92.6 1.2 0 0.3 5.9 42.3 33.9 9.4 29.6 
K5 
26.2 5.6 10.1 15.9 47.6 47 831 84.1 5 0.1 0.2 10.6 10.5 8.3 2.3 6.5 
K6 
28 7.1 9.3 14.7 44.1 47 818 90.5 1.6 0 0.3 7.6 41.3 31.6 7 26.1 
K7 
28.7 8 8.8 14 41.3 47 347 88.2 3.2 0.1 0.3 8.2 13.4 8.4 5.3 5.1 
K8 
24.2 7.2 9 14.8 42.6 47 926 92.6 0.9 0.2 0.4 5.9 13 8.5 4.6 13.2 
K9 
25 5.2 9.1 14.6 42.8 47 587 88.9 1.1 0.5 0.5 9 16.9 11.6 4.7 4.9 
K10 
24.4 6.1 8.8 14.2 41.7 47 642 82.9 5 0.4 0.5 11.2 13.1 9.3 3.8 4 
K11 
28 6.4 9 14.1 42.8 48 867 86.1 5.2 0.2 0.6 7.9 32.5 25.6 9.5 14.1 
K12 
25 No blood No blood No blood No blood No blood No blood No blood No blood No blood No blood No blood 1.8 1.5 1 1.4 
K13 
26.4 4.4 8.4 13.6 39.9 47 747 87.7 3.6 0.4 0.6 7.7 11.6 7.3 4.4 4.9 
K14 
24.4 7.4 9.2 14.7 43.4 47 792 84.9 3.7 1 0.6 9.8 16.1 10.5 8.5 24.7 
K15 
31.2 4.9 8.9 14 41.2 46 405 84.4 5.5 0.1 0.3 9.7 14.3 9.4 5.4 4.3 
K16 
28.5 7.9 9.5 14.7 44.9 47 1066 88 2.5 0.1 0.4 9 39.8 30.6 8.6 40 
K17 
26.3 7.8 8.6 14.4 41.1 48 1031 82 4.8 0.8 0.5 11.9 7.9 5.7 2 5.9 
K18 
26.2 9 9.8 15.3 46.5 47 1161 89.1 2.8 0.1 0.4 7.6 41.8 31.7 9.9 41.4 
K19 
25.2 5.1 9.1 14.7 43.7 48 825 84.8 3.3 0.2 0.4 11.3 26.2 19.6 8.3 8 
K20 
28.2 5.8 9.6 15.2 45.7 48 1025 89.3 1.9 0.2 0.5 8.1 56.2 42.6 14.4 29.9 
K21 
25.7 7.8 9.7 15.2 45.8 47 807 88.1 2.5 0.1 0.4 8.9 31.8 22.4 8.8 19.3 
K22 
25.1 5.5 8.4 13.9 39.3 47 1205 82.8 5.8 0.9 0.7 9.8 11.4 8.6 1.3 5.4 
K23 
24 5.1 9.1 14.8 43.7 48 1185 83.4 3.1 0.3 0.3 12.9 19.3 14.9 3.1 15.6 
K24 
28.6 7.1 9.8 15.8 46.9 48 1093 89 2.5 0.1 0.3 8.1 41.9 33.8 10.4 44.1 
K25 
25.3 7.7 9.2 14.6 43.9 48 1026 86.5 3.3 0.6 0.3 9.3 28.6 22 6.2 30.6 
Average 
25.8 6.9 9.35 14.9 44.65 48 900.5 87.8 3.25 0.3 0.3 8.35 18 13.65 4.45 16.4 
 
 
